<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34638636</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>19</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10285</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms221910285</ELocationID><Abstract><AbstractText>RNA metabolism is central to cellular physiopathology. Almost all the molecular pathways underpinning biological processes are affected by the events governing the RNA life cycle, ranging from transcription to degradation. The deregulation of these processes contributes to the onset and progression of human diseases. In recent decades, considerable efforts have been devoted to the characterization of noncoding RNAs (ncRNAs) and to the study of their role in the homeostasis of the nervous system (NS), where they are highly enriched. Acting as major regulators of gene expression, ncRNAs orchestrate all the steps of the differentiation programs, participate in the mechanisms underlying neural functions, and are crucially implicated in the development of neuronal pathologies, among which are neurodegenerative diseases. This review aims to explore the link between ncRNA dysregulation and amyotrophic lateral sclerosis (ALS), the most frequent motoneuron (MN) disorder in adults. Notably, defective RNA metabolism is known to be largely associated with this pathology, which is often regarded as an RNA disease. We also discuss the potential role that these transcripts may play as diagnostic biomarkers and therapeutic targets.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laneve</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8865-4038</Identifier><AffiliationInfo><Affiliation>Institute of Molecular Biology and Pathology, National Research Council, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tollis</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caffarelli</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Pathology, National Research Council, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PRIN 2017 (prot. 2017P352Z4)</GrantID><Agency>Ministero dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022661">RNA, Untranslated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022661" MajorTopicYN="N">RNA, Untranslated</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">RNA metabolism</Keyword><Keyword MajorTopicYN="N">circular RNAs</Keyword><Keyword MajorTopicYN="N">long noncoding RNAs</Keyword><Keyword MajorTopicYN="N">microRNAs</Keyword><Keyword MajorTopicYN="N">motoneurons</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">noncoding RNAs</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34638636</ArticleId><ArticleId IdType="pmc">PMC8508793</ArticleId><ArticleId IdType="doi">10.3390/ijms221910285</ArticleId><ArticleId IdType="pii">ijms221910285</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Robberecht W., Philips T. The Changing Scene of Amyotrophic Lateral Sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The Phenotypic Variability of Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T.M., Alberman E., Swash M. Comparison of Sporadic and Familial Disease amongst 580 Cases of Motor Neuron Disease. J. Neurol. Neurosurg. Psychiatry. 1988;51:778&#x2013;784. doi: 10.1136/jnnp.51.6.778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.51.6.778</ArticleId><ArticleId IdType="pmc">PMC1033147</ArticleId><ArticleId IdType="pubmed">3404186</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Brown R.H. Molecular Biology of Amyotrophic Lateral Sclerosis: Insights from Genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical Genetics of Amyotrophic Lateral Sclerosis: What Do We Really Know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel Genes Associated with Amyotrophic Lateral Sclerosis: Diagnostic and Clinical Implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Battistini S., Calvo A., Caponnetto C., Conforti F.L., Corbo M., Giannini F., Mandrioli J., Mora G., Sabatelli M., et al. Genetic Counselling in ALS: Facts, Uncertainties and Clinical Suggestions. J. Neurol. Neurosurg. Psychiatry. 2014;85:478&#x2013;485. doi: 10.1136/jnnp-2013-305546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-305546</ArticleId><ArticleId IdType="pubmed">23833266</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J., Corbera-Bellalta M., Nogales G., Raguer N., Garc&#xed;a-Arum&#xed; E., Badia-Canto M., Llad&#xf3;-Carb&#xf3; E., &#xc1;lvarez-Sab&#xed;n J. Mutational Analysis of the Cu/Zn Superoxide Dismutase Gene in a Catalan ALS Population: Should All Sporadic ALS Cases Also Be Screened for SOD1? J. Neurol. Sci. 2006;247:21&#x2013;28. doi: 10.1016/j.jns.2006.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.03.006</ArticleId><ArticleId IdType="pubmed">16674979</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Hewitt C., Highley J.R., Brockington A., Milano A., Man S., Martindale J., Hartley J., Walsh T., Gelsthorpe C., et al. Clinico-Pathological Features in Amyotrophic Lateral Sclerosis with Expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From Genes to Mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Portz B., Lee B.L., Shorter J. FUS and TDP-43 Phases in Health and Disease. Trends Biochem. Sci. 2021;46:550&#x2013;563. doi: 10.1016/j.tibs.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC8195841</ArticleId><ArticleId IdType="pubmed">33446423</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Chen W., Hong S.-T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 Cause Dominant X-Linked Juvenile and Adult-Onset ALS and ALS/Dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., et al. SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Arch. Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss-Coray T. Ageing, Neurodegeneration and Brain Rejuvenation. Nature. 2016;539:180&#x2013;186. doi: 10.1038/nature20411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20411</ArticleId><ArticleId IdType="pmc">PMC5172605</ArticleId><ArticleId IdType="pubmed">27830812</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.-C., Sun E., Wancewicz E., Mazur C., et al. Long Pre-MRNA Depletion and RNA Missplicing Contribute to Neuronal Vulnerability from Loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E.S., Ling S.-C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A., et al. ALS-Linked TDP-43 Mutations Produce Aberrant RNA Splicing and Adult-Onset Motor Neuron Disease without Aggregation or Loss of Nuclear TDP-43. Proc. Natl. Acad. Sci. USA. 2013;110:E736&#x2013;E745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Front. Genet. 2019;10:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory R.I., Yan K., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor Complex Mediates the Genesis of MicroRNAs. Nature. 2004;432:235&#x2013;240. doi: 10.1038/nature03120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03120</ArticleId><ArticleId IdType="pubmed">15531877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Albuquerque C.P., Han J.S., Lagier-Tourenne C., Tokunaga S., Zhou H., Cleveland D.W. ALS-Associated Mutations in TDP-43 Increase Its Stability and Promote TDP-43 Complexes with FUS/TLS. Proc. Natl. Acad. Sci. USA. 2010;107:13318&#x2013;13323. doi: 10.1073/pnas.1008227107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Charcot J.-M., Joffroy A. Deux Cas d&#x2019;atrophie Musculaire Progressive Avec L&#xe9;sions de La Substance Grise et Des Faisceaux Ant&#xe9;rolat&#xe9;raux de La Moelle &#xc9;pini&#xe8;re. Arch. Physiol. Norm. Pathol. 1869;2:744&#x2013;760.</Citation></Reference><Reference><Citation>Kurland L.K., Mulder D.W. Epidemiologic Investigations of Amyotrophic Lateral Sclerosis: 1. Preliminary Report on Geographic Distribution, with Special Reference to the Mariana Islands, Including Clinical and Pathologic Observations. Neurology. 1954;4:355&#x2013;378. doi: 10.1212/WNL.4.5.355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.4.5.355</ArticleId><ArticleId IdType="pubmed">13185376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder D.W. Epidemiologic Investigations of Amyotrophic Lateral Sclerosis: 2. Familial Aggregations Indicative of Dominant Inheritance Part II. Neurology. 1955;5:249&#x2013;268. doi: 10.1212/wnl.5.4.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.5.4.249</ArticleId><ArticleId IdType="pubmed">14370376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesalingam J., Stahl D., Wijesekera L., Galtrey C., Shaw C.E., Leigh P.N., Al-Chalabi A. Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups. PLoS ONE. 2009;4:e7107. doi: 10.1371/journal.pone.0007107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0007107</ArticleId><ArticleId IdType="pmc">PMC2741575</ArticleId><ArticleId IdType="pubmed">19771164</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E., Chipika R.H., Li Hi Shing S., Hardiman O., Bede P. Pathological Crying and Laughing in Motor Neuron Disease: Pathobiology, Screening, Intervention. Front. Neurol. 2019;10:260. doi: 10.3389/fneur.2019.00260.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00260</ArticleId><ArticleId IdType="pmc">PMC6438102</ArticleId><ArticleId IdType="pubmed">30949121</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape J.A., Grose J.H. The Effects of Diet and Sex in Amyotrophic Lateral Sclerosis. Rev. Neurol. (Paris) 2020;176:301&#x2013;315. doi: 10.1016/j.neurol.2019.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pmc">PMC8915943</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F., D&#x2019;Alvano G., Bonavita S., Tedeschi G. Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link? Int. J. Mol. Sci. 2020;21:3647. doi: 10.3390/ijms21103647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103647</ArticleId><ArticleId IdType="pmc">PMC7279172</ArticleId><ArticleId IdType="pubmed">32455692</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H., Mehal J.M., Holman R.C., Rowland L.P., Rowland A.S., Cheek J.E. Incidence of Amyotrophic Lateral Sclerosis Among American Indians and Alaska Natives. JAMA Neurol. 2013;70:476&#x2013;480. doi: 10.1001/jamaneurol.2013.929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.929</ArticleId><ArticleId IdType="pubmed">23440294</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chi&#xf2; A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E., EURALS Incidence of Amyotrophic Lateral Sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Traynor B.J., Collins J., Simeone J.C., Goldstein L.A., White L.A. Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G., Eurals Consortium Prognostic Factors in ALS: A Critical Review. Amyotroph. Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>del Aguila M.A., Longstreth W.T., McGuire V., Koepsell T.D., van Belle G. Prognosis in Amyotrophic Lateral Sclerosis. Neurology. 2003;60:813&#x2013;819. doi: 10.1212/01.WNL.0000049472.47709.3B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000049472.47709.3B</ArticleId><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Parton M.J., Shaw C.E., Leigh P.N., Al-Chalabi A. Prolonged Survival in Motor Neuron Disease: A Descriptive Study of the King&#x2019;s Database 1990&#x2013;2002. J. Neurol. Neurosurg. Psychiatry. 2003;74:995&#x2013;997. doi: 10.1136/jnnp.74.7.995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.74.7.995</ArticleId><ArticleId IdType="pmc">PMC1738535</ArticleId><ArticleId IdType="pubmed">12810805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Moglia C., Mazzini L., Mora G., PARALS Study Group Phenotypic Heterogeneity of Amyotrophic Lateral Sclerosis: A Population Based Study. J. Neurol. Neurosurg. Psychiatry. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2009;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G., Lacomblez L., Meininger V., ALS/Riulzole Study Group A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2010;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi D., Meneri M., Saccomanno D., Bresolin N., Comi G.P., Corti S. Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature. Int. J. Mol. Sci. 2019;20:4152. doi: 10.3390/ijms20174152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20174152</ArticleId><ArticleId IdType="pmc">PMC6747516</ArticleId><ArticleId IdType="pubmed">31450699</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K., De Schaepdryver M., Stubendorff B., Gille B., Muckova P., Wendler S., Prell T., Ringer T.M., Rhode H., Stevens O., et al. Neurofilament Markers for ALS Correlate with Extent of Upper and Lower Motor Neuron Disease. Neurology. 2017;88:2302&#x2013;2309. doi: 10.1212/WNL.0000000000004029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004029</ArticleId><ArticleId IdType="pubmed">28500227</ArticleId></ArticleIdList></Reference><Reference><Citation>Falzone Y.M., Domi T., Agosta F., Pozzi L., Schito P., Fazio R., Del Carro U., Barbieri A., Comola M., Leocani L., et al. Serum Phosphorylated Neurofilament Heavy-Chain Levels Reflect Phenotypic Heterogeneity and Are an Independent Predictor of Survival in Motor Neuron Disease. J. Neurol. 2020;267:1. doi: 10.1007/s00415-020-09838-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09838-9</ArticleId><ArticleId IdType="pmc">PMC7166001</ArticleId><ArticleId IdType="pubmed">32306171</ArticleId></ArticleIdList></Reference><Reference><Citation>De Schaepdryver M., Jeromin A., Gille B., Claeys K.G., Herbst V., Brix B., Van Damme P., Poesen K. Comparison of Elevated Phosphorylated Neurofilament Heavy Chains in Serum and Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry. 2018;89:367&#x2013;373. doi: 10.1136/jnnp-2017-316605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316605</ArticleId><ArticleId IdType="pubmed">29054919</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F.M., Grierson A.J., Cookson M.R., Heath P.R., Tomkins J., Figlewicz D.A., Ince P.G., Shaw P.J. Selective Loss of Neurofilament Expression in Cu/Zn Superoxide Dismutase (SOD1) Linked Amyotrophic Lateral Sclerosis. J. Neurochem. 2002;82:1118&#x2013;1128. doi: 10.1046/j.1471-4159.2002.01045.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01045.x</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Zheng L., Viera L., Suswam E., Li Y., Li X., Est&#xe9;vez A.G., King P.H. Mutant Cu/Zn-Superoxide Dismutase Associated with Amyotrophic Lateral Sclerosis Destabilizes Vascular Endothelial Growth Factor MRNA and Downregulates Its Expression. J. Neurosci. 2007;27:7929&#x2013;7938. doi: 10.1523/JNEUROSCI.1877-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1877-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672720</ArticleId><ArticleId IdType="pubmed">17652584</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Qian K., Du Z., Cao J., Petersen A., Liu H., Blackbourn L.W., Huang C.L., Errigo A., Yin Y., et al. Modeling ALS with IPSCs Reveals That Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons. Cell Stem Cell. 2014;14:796&#x2013;809. doi: 10.1016/j.stem.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.02.004</ArticleId><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J. The Evidence for Altered RNA Metabolism in Amyotrophic Lateral Sclerosis (ALS) J. Neurol. Sci. 2010;288:1&#x2013;12. doi: 10.1016/j.jns.2009.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.09.029</ArticleId><ArticleId IdType="pubmed">19840884</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E., Renton A.E., Mok K., Dopper E.G.P., Waite A., Rollinson S., Chi&#xf2; A., Restagno G., Nicolaou N., Simon-Sanchez J., et al. Frequency of the C9orf72 Hexanucleotide Repeat Expansion in Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: A Cross-Sectional Study. Lancet Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Bieniek K.F., Zhang Y.J., Jansen-West K., Ash P.E.A., Caulfield T., Daughrity L., Dunmore J.H., Castanedes-Casey M., Chew J., et al. Antisense Transcripts of the Expanded C9ORF72 Hexanucleotide Repeat Form Nuclear RNA Foci and Undergo Repeat-Associated Non-ATG Translation in C9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.J., Zhang P.W., Pham J.T., Heusler A.R., Mistry N.A., Vidensky S., Daley E.L., Poth E.M., Hoover B., Fines D.M., et al. RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention. Neuron. 2013;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.B., Chen H.J., Peres J.N., Gomez-Deza J., Attig J., &#x160;talekar M., Troakes C., Nishimura A.L., Scotter E.L., Vance C., et al. Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic. Cell Rep. 2013;5:1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.-M., Arzberger T., May S., Rentzsch K., Kremmer E., Schmid B., Kretzschmar H.A., Cruts M., Van Broeckhoven C., et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Baughn M., Rigo F., Sun S., Liu P., Li H.-R., Jiang J., Watt A.T., Chun S., Katz M., et al. Targeted Degradation of Sense and Antisense C9orf72 RNA Foci as Therapy for ALS and Frontotemporal Degeneration. Proc. Natl. Acad. Sci. USA. 2013;110:E4530&#x2013;E4539. doi: 10.1073/pnas.1318835110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong G.A.B., Drapeau P. Calcium Channel Agonists Protect against Neuromuscular Dysfunction in a Genetic Model of TDP-43 Mutation in ALS. J. Neurosci. 2013;33:1741&#x2013;1752. doi: 10.1523/JNEUROSCI.4003-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4003-12.2013</ArticleId><ArticleId IdType="pmc">PMC6618732</ArticleId><ArticleId IdType="pubmed">23345247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Wang S., Zheng L., Li X., Suswam E.A., Zhang X., Wheeler C.G., Nabors L.B., Filippova N., King P.H. Amyotrophic Lateral Sclerosis-Linked Mutant SOD1 Sequesters Hu Antigen R (HuR) and TIA-1-Related Protein (TIAR) J. Biol. Chem. 2009;284:33989&#x2013;33998. doi: 10.1074/jbc.M109.067918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.067918</ArticleId><ArticleId IdType="pmc">PMC2797169</ArticleId><ArticleId IdType="pubmed">19805546</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F., Godena V.K., Romano G., D&#x2019;Ambrogio A., Klima R., Baralle F.E. Depletion of TDP-43 Affects Drosophila Motoneurons Terminal Synapsis and Locomotive Behavior. FEBS Lett. 2009;583:1586&#x2013;1592. doi: 10.1016/j.febslet.2009.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pubmed">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Cenik C., Kucukural A., Dammer E.B., Cenik B., Han Y.H., Dewey C.M., Roth F.P., Herz J., Peng J., et al. Identification of Neuronal RNA Targets of TDP-43-Containing Ribonucleoprotein Complexes. J. Biol. Chem. 2011;286:1204&#x2013;1215. doi: 10.1074/jbc.M110.190884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.190884</ArticleId><ArticleId IdType="pmc">PMC3020728</ArticleId><ArticleId IdType="pubmed">21051541</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Carlo V., Grossi E., Laneve P., Morlando M., Dini Modigliani S., Ballarino M., Bozzoni I., Caffarelli E. TDP-43 Regulates the Microprocessor Complex Activity during in Vitro Neuronal Differentiation. Mol. Neurobiol. 2013;48:952&#x2013;963. doi: 10.1007/s12035-013-8564-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8564-x</ArticleId><ArticleId IdType="pubmed">24113842</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog J.J., Deshpande M., Shapiro L., Rodal A.A., Paradis S. TDP-43 Misexpression Causes Defects in Dendritic Growth. Sci. Rep. 2017;7:15656. doi: 10.1038/s41598-017-15914-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15914-4</ArticleId><ArticleId IdType="pmc">PMC5688077</ArticleId><ArticleId IdType="pubmed">29142232</ArticleId></ArticleIdList></Reference><Reference><Citation>Handley E.E., Pitman K.A., Dawkins E., Young K.M., Clark R.M., Jiang T.C., Turner B.J., Dickson T.C., Blizzard C.A. Synapse Dysfunction of Layer V Pyramidal Neurons Precedes Neurodegeneration in a Mouse Model of TDP-43 Proteinopathies. Cereb. Cortex. 2017;27:3630&#x2013;3647. doi: 10.1093/cercor/bhw185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhw185</ArticleId><ArticleId IdType="pubmed">27496536</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological Functions and Pathobiology of TDP-43 and FUS/TLS Proteins. J. Neurochem. 2016;138:95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., De Conti L., Stuani C., Romano M., Baralle M., Baralle F. Nuclear Factor TDP-43 Can Affect Selected MicroRNA Levels. FEBS J. 2010;277:2268&#x2013;2281. doi: 10.1111/j.1742-4658.2010.07643.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07643.x</ArticleId><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y., Mieda-Sato A. TDP-43 Promotes MicroRNA Biogenesis as a Component of the Drosha and Dicer Complexes. Proc. Natl. Acad. Sci. USA. 2012;109:3347&#x2013;3352. doi: 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Almeida S., Lu Y., Nishimura A.L., Peng L., Sun D., Wu B., Karydas A.M., Tartaglia M.C., Fong J.C., et al. Downregulation of MicroRNA-9 in IPSC-Derived Neurons of FTD/ALS Patients with TDP-43 Mutations. PLoS ONE. 2013;8:e76055. doi: 10.1371/journal.pone.0076055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076055</ArticleId><ArticleId IdType="pmc">PMC3797144</ArticleId><ArticleId IdType="pubmed">24143176</ArticleId></ArticleIdList></Reference><Reference><Citation>King I.N., Yartseva V., Salas D., Kumar A., Heidersbach A., Ando D.M., Stallings N.R., Elliott J.L., Srivastava D., Ivey K.N. The RNA-Binding Protein TDP-43 Selectively Disrupts MicroRNA-1/206 Incorporation into the RNA-Induced Silencing Complex. J. Biol. Chem. 2014;289:14263&#x2013;14271. doi: 10.1074/jbc.M114.561902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.561902</ArticleId><ArticleId IdType="pmc">PMC4022891</ArticleId><ArticleId IdType="pubmed">24719334</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Onesto E., Megiorni F., Pizzuti A., Baralle F.E., Buratti E., Silani V., Ratti A. TDP-43 and FUS RNA-Binding Proteins Bind Distinct Sets of Cytoplasmic Messenger RNAs and Differently Regulate Their Post-Transcriptional Fate in Motoneuron-like Cells. J. Biol. Chem. 2012;287:15635. doi: 10.1074/jbc.M111.333450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.333450</ArticleId><ArticleId IdType="pmc">PMC3346140</ArticleId><ArticleId IdType="pubmed">22427648</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H., Sok J., Immanuel D., Yin Y., Ron D. TLS (FUS) Binds RNA in Vivo and Engages in Nucleo-Cytoplasmic Shuttling. J. Cell Sci. 1997;110:1741&#x2013;1750. doi: 10.1242/jcs.110.15.1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.110.15.1741</ArticleId><ArticleId IdType="pubmed">9264461</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii R., Okabe S., Urushido T., Inoue K., Yoshimura A., Tachibana T., Nishikawa T., Hicks G.G., Takumi T. The RNA Binding Protein TLS Is Translocated to Dendritic Spines by MGluR5 Activation and Regulates Spine Morphology. Curr. Biol. 2005;15:587&#x2013;593. doi: 10.1016/j.cub.2005.01.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2005.01.058</ArticleId><ArticleId IdType="pubmed">15797031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii R., Takumi T. TLS Facilitates Transport of MRNA Encoding an Actin-Stabilizing Protein to Dendritic Spines. J. Cell Sci. 2005;118:5755&#x2013;5765. doi: 10.1242/jcs.02692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02692</ArticleId><ArticleId IdType="pubmed">16317045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., LeClerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Haass C. Fused in Sarcoma (FUS): An Oncogene Goes Awry in Neurodegeneration. Mol. Cell. Neurosci. 2013;56:475&#x2013;486. doi: 10.1016/j.mcn.2013.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2013.03.006</ArticleId><ArticleId IdType="pubmed">23557964</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle G.G., Lanson N.A., Smith R.B., Casci I., Maltare A., Monaghan J., Nichols C.D., Kryndushkin D., Shewmaker F., Pandey U.B. Rna-Binding Ability of FUS Regulates Neurodegeneration, Cytoplasmic Mislocalization and Incorporation into Stress Granules Associated with FUS Carrying ALS-Linked Mutations. Hum. Mol. Genet. 2013;22:1193&#x2013;1205. doi: 10.1093/hmg/dds526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds526</ArticleId><ArticleId IdType="pmc">PMC3578413</ArticleId><ArticleId IdType="pubmed">23257289</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Zucca S., Pandini C., Diamanti L., Bordoni M., Sproviero D., Arigoni M., Olivero M., Pansarasa O., Ceroni M., et al. Long Non-Coding and Coding RNAs Characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis Patients. Sci. Rep. 2018;8:2378. doi: 10.1038/s41598-018-20679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId><ArticleId IdType="pmc">PMC5799454</ArticleId><ArticleId IdType="pubmed">29402919</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo M., Pandini C., Bordoni M., Pansarasa O., Rey F., Costa A., Minafra B., Diamanti L., Zucca S., Carelli S., et al. Alzheimer&#x2019;s, Parkinson&#x2019;s Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement. Int. J. Mol. Sci. 2020;21:9500. doi: 10.3390/ijms21249500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249500</ArticleId><ArticleId IdType="pmc">PMC7765024</ArticleId><ArticleId IdType="pubmed">33327559</ArticleId></ArticleIdList></Reference><Reference><Citation>Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., et al. The Transcriptional Landscape of the Mammalian Genome. Science. 2005;309:1559&#x2013;1563. doi: 10.1126/SCIENCE.1112014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.1112014</ArticleId><ArticleId IdType="pubmed">16141072</ArticleId></ArticleIdList></Reference><Reference><Citation>Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., et al. Landscape of Transcription in Human Cells. Nature. 2012;489:101&#x2013;108. doi: 10.1038/nature11233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11233</ArticleId><ArticleId IdType="pmc">PMC3684276</ArticleId><ArticleId IdType="pubmed">22955620</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunham I., Kundaje A., Aldred S.F., Collins P.J., Davis C.A., Doyle F., Epstein C.B., Frietze S., Harrow J., Kaul R., et al. An Integrated Encyclopedia of DNA Elements in the Human Genome. Nature. 2012;489:57&#x2013;74. doi: 10.1038/nature11247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11247</ArticleId><ArticleId IdType="pmc">PMC3439153</ArticleId><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. Metazoan MicroRNAs. Cell. 2018;173:20&#x2013;51. doi: 10.1016/j.cell.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert M.S., Sharp P.A. Roles for MicroRNAs in Conferring Robustness to Biological Processes. Cell. 2012;149:515&#x2013;524. doi: 10.1016/j.cell.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.005</ArticleId><ArticleId IdType="pmc">PMC3351105</ArticleId><ArticleId IdType="pubmed">22541426</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloutier F., Marrero A., O&#x2019;Connell C., Morin P.J. MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis. J. Mol. Neurosci. 2014;56:102&#x2013;112. doi: 10.1007/s12031-014-0471-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-014-0471-8</ArticleId><ArticleId IdType="pubmed">25433762</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rie D., Abugessaisa I., Alam T., Arner E., Arner P., Ashoor H., &#xc5;str&#xf6;m G., Babina M., Bertin N., Burroughs A.M., et al. An Integrated Expression Atlas of MiRNAs and Their Promoters in Human and Mouse. Nat. Biotechnol. 2017;35:872&#x2013;878. doi: 10.1038/nbt.3947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3947</ArticleId><ArticleId IdType="pmc">PMC5767576</ArticleId><ArticleId IdType="pubmed">28829439</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien J., Hayder H., Zayed Y., Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol. (Lausanne) 2018;9:402. doi: 10.3389/fendo.2018.00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00402</ArticleId><ArticleId IdType="pmc">PMC6085463</ArticleId><ArticleId IdType="pubmed">30123182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zolboot N., Du J.X., Zampa F., Lippi G. MicroRNAs Instruct and Maintain Cell Type Diversity in the Nervous System. Front. Mol. Neurosci. 2021;14:69. doi: 10.3389/fnmol.2021.646072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.646072</ArticleId><ArticleId IdType="pmc">PMC8116551</ArticleId><ArticleId IdType="pubmed">33994943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y.-L., Yoo A.S. Mechanistic Insights into MicroRNA-Induced Neuronal Reprogramming of Human Adult Fibroblasts. Front. Neurosci. 2018;12:522. doi: 10.3389/fnins.2018.00522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00522</ArticleId><ArticleId IdType="pmc">PMC6083049</ArticleId><ArticleId IdType="pubmed">30116172</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered MicroRNA Expression Profile in Amyotrophic Lateral Sclerosis: A Role in the Regulation of NFL MRNA Levels. Mol. Brain. 2013;6:26. doi: 10.1186/1756-6606-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A., Eitan C., Liou L.-L., Libby R.T., Rivkin N., Magen I., Reichenstein I., Oppenheim H., Eilam R., Silvestroni A., et al. Dysregulated MiRNA Biogenesis Downstream of Cellular Stress and ALS-Causing Mutations: A New Mechanism for ALS. EMBO J. 2015;34:2633&#x2013;2651. doi: 10.15252/embj.201490493.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Lunn J.S., Paez-Colasante X., Bender D.E., Yung R., Sakowski S.A., Feldman E.L. Expression of MicroRNAs in Human Post-Mortem Amyotrophic Lateral Sclerosis Spinal Cords Provides Insight into Disease Mechanisms. Mol. Cell. Neurosci. 2016;71:34&#x2013;45. doi: 10.1016/j.mcn.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.008</ArticleId><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuti M., Filosa G., Melzi V., Calandriello L., Dioni L., Bollati V., Bresolin N., Comi G.P., Barabino S., Nizzardo M., et al. MicroRNA Expression Analysis Identifies a Subset of Downregulated MiRNAs in ALS Motor Neuron Progenitors. Sci. Rep. 2018;8:10105. doi: 10.1038/s41598-018-28366-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28366-1</ArticleId><ArticleId IdType="pmc">PMC6031650</ArticleId><ArticleId IdType="pubmed">29973608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Woldemichael B.T., Kremer E.A., Laferriere F., Gaur N., Afroz T., Polymenidou M., Mansuy I.M. Memory Decline and Its Reversal in Aging and Neurodegeneration Involve MiR-183/96/182 Biogenesis. Mol. Neurobiol. 2018;56:3451&#x2013;3462. doi: 10.1007/s12035-018-1314-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1314-3</ArticleId><ArticleId IdType="pubmed">30128653</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante X., Figueroa-Romero C., Rumora A.E., Hur J., Mendelson F.E., Hayes J.M., Backus C., Taubman G.F., Heinicke L., Walter N.G., et al. Cytoplasmic TDP43 Binds MicroRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2020;14:117. doi: 10.3389/fncel.2020.00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00117</ArticleId><ArticleId IdType="pmc">PMC7235295</ArticleId><ArticleId IdType="pubmed">32477070</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X., Zhou J., Li Y., Wu K., Chen Z., Luo Z., Zhang X., Liang Y., Esteban M.A., Zhou Y., et al. TDP-43 Aggregation Induced by Oxidative Stress Causes Global Mitochondrial Imbalance in ALS. Nat. Struct. Mol. Biol. 2021;28:132&#x2013;142. doi: 10.1038/s41594-020-00537-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00537-7</ArticleId><ArticleId IdType="pubmed">33398173</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M., Modigliani S.D., Torrelli G., Rosa A., Di Carlo V., Caffarelli E., Bozzoni I. FUS Stimulates MicroRNA Biogenesis by Facilitating Co-Transcriptional Drosha Recruitment. EMBO J. 2012;31:4502&#x2013;4510. doi: 10.1038/emboj.2012.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.319</ArticleId><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Wu Y.-C., Mullane P., Ji Y.J., Liu H., He L., Arora A., Hwang H.-Y., Alessi A.F., Niaki A.G., et al. FUS Regulates Activity of MicroRNA-Mediated Gene Silencing. Mol. Cell. 2018;69:787&#x2013;801.e8. doi: 10.1016/j.molcel.2018.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.001</ArticleId><ArticleId IdType="pmc">PMC5836505</ArticleId><ArticleId IdType="pubmed">29499134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley Z.C.E., Campos-Melo D., Strong M.J. Evidence of a Negative Feedback Network between TDP-43 and MiRNAs Dependent on TDP-43 Nuclear Localization. J. Mol. Biol. 2020;432:166695. doi: 10.1016/j.jmb.2020.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.10.029</ArticleId><ArticleId IdType="pubmed">33137311</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley Z.C.E., Campos-Melo D., Strong M.J. Novel MiR-B2122 Regulates Several ALS-Related RNA-Binding Proteins. Mol. Brain. 2017;10:46. doi: 10.1186/s13041-017-0326-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0326-7</ArticleId><ArticleId IdType="pmc">PMC5625648</ArticleId><ArticleId IdType="pubmed">28969660</ArticleId></ArticleIdList></Reference><Reference><Citation>Dini Modigliani S., Morlando M., Errichelli L., Sabatelli M., Bozzoni I. An ALS-Associated Mutation in the FUS 3&#x2032;-UTR Disrupts a MicroRNA&#x2013;FUS Regulatory Circuitry. Nat. Commun. 2014;5:4335. doi: 10.1038/ncomms5335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5335</ArticleId><ArticleId IdType="pubmed">25004804</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitan C., Hornstein E. Vulnerability of MicroRNA Biogenesis in FTD&#x2013;ALS. Brain Res. 2016;1647:105&#x2013;111. doi: 10.1016/j.brainres.2015.12.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.12.063</ArticleId><ArticleId IdType="pubmed">26778173</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinde S., Arora N., Bhadra U. A Complex Network of MicroRNAs Expressed in Brain and Genes Associated with Amyotrophic Lateral Sclerosis. Int. J. Genom. 2013;2013:383024. doi: 10.1155/2013/383024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/383024</ArticleId><ArticleId IdType="pmc">PMC3723150</ArticleId><ArticleId IdType="pubmed">23936767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamzeiy H., Suluyayla R., Brinkrolf C., Janowski S.J., Hofest&#xe4;dt R., Allmer J. Visualization and Analysis of MiRNAs Implicated in Amyotrophic Lateral Sclerosis Within Gene Regulatory Pathways. Ger. Med. Data Sci. 2018;253:183&#x2013;187. doi: 10.3233/978-1-61499-896-9-183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-896-9-183</ArticleId><ArticleId IdType="pubmed">30147069</ArticleId></ArticleIdList></Reference><Reference><Citation>Recabarren-Leiva D., Alarc&#xf3;n M. New Insights into the Gene Expression Associated to Amyotrophic Lateral Sclerosis. Life Sci. 2018;193:110&#x2013;123. doi: 10.1016/j.lfs.2017.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2017.12.016</ArticleId><ArticleId IdType="pubmed">29241710</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Zuo X., Zhang P., Zhao R., Lai D., Chen K., Han Y., Wan G., Zheng Y., Lu C., et al. The Novel Regulatory Role of LncRNA-MiRNA-MRNA Axis in Amyotrophic Lateral Sclerosis: An Integrated Bioinformatics Analysis. Comput. Math. Methods Med. 2021;2021:5526179. doi: 10.1155/2021/5526179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5526179</ArticleId><ArticleId IdType="pmc">PMC8067776</ArticleId><ArticleId IdType="pubmed">33953791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitropoulos K., Katsila T., Patrinos G.P., Pampalakis G. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis. Omics A J. Integr. Biol. 2018;22:52&#x2013;64. doi: 10.1089/omi.2017.0183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2017.0183</ArticleId><ArticleId IdType="pubmed">29356625</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotem N., Magen I., Ionescu A., Gershoni-Emek N., Altman T., Costa C.J., Gradus T., Pasmanik-Chor M., Willis D.E., Ben-Dov I.Z., et al. ALS Along the Axons&#x2013;Expression of Coding and Noncoding RNA Differs in Axons of ALS Models. Sci. Rep. 2017;7:44500. doi: 10.1038/srep44500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44500</ArticleId><ArticleId IdType="pmc">PMC5353576</ArticleId><ArticleId IdType="pubmed">28300211</ArticleId></ArticleIdList></Reference><Reference><Citation>Helferich A.M., Brockmann S.J., Reinders J., Deshpande D., Holzmann K., Brenner D., Andersen P.M., Petri S., Thal D.R., Michaelis J., et al. Dysregulation of a Novel MiR-1825/TBCB/TUBA4A Pathway in Sporadic and Familial ALS. Cell. Mol. Life Sci. 2018;75:4301&#x2013;4319. doi: 10.1007/s00018-018-2873-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2873-1</ArticleId><ArticleId IdType="pubmed">30030593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.Y., Kim Y.R., Choi K.W., Lee M., Lee S., Im W., Shin J.Y., Kim J.Y., Hong Y.H., Kim M., et al. Downregulated MiR-18b-5p Triggers Apoptosis by Inhibition of Calcium Signaling and Neuronal Cell Differentiation in Transgenic SOD1 (G93A) Mice and SOD1 (G17S and G86S) ALS Patients. Transl. Neurodegener. 2020;9:23. doi: 10.1186/s40035-020-00203-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00203-4</ArticleId><ArticleId IdType="pmc">PMC7328278</ArticleId><ArticleId IdType="pubmed">32605607</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Goswami A., Limm K., Zimyanin V.L., Demestre M., Gla&#xdf; H., Holzmann K., Helferich A.M., Brockmann S.J., Tripathi P., et al. A Serum MicroRNA Sequence Reveals Fragile X Protein Pathology in Amyotrophic Lateral Sclerosis. Brain. 2021;144:1214&#x2013;1229. doi: 10.1093/brain/awab018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab018</ArticleId><ArticleId IdType="pmc">PMC8105042</ArticleId><ArticleId IdType="pubmed">33871026</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., M&#xfc;ller K., Zondler L., Weydt P., Volk A.E., Bo&#x17e;i&#x10d; A.L., Walter M., Bonin M., Mayer B., von Arnim C.A.F., et al. Serum MicroRNAs in Patients with Genetic Amyotrophic Lateral Sclerosis and Pre-Manifest Mutation Carriers. Brain. 2014;137:2938&#x2013;2950. doi: 10.1093/brain/awu249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu249</ArticleId><ArticleId IdType="pubmed">25193138</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., M&#xfc;ller K., Zondler L., Weydt P., Mayer B., von Arnim C.A.F., H&#xfc;bers A., Dorst J., Otto M., Holzmann K., et al. Serum MicroRNAs in Sporadic Amyotrophic Lateral Sclerosis. Neurobiol. Aging. 2015;36:2660.e15&#x2013;2660.e20. doi: 10.1016/j.neurobiolaging.2015.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.06.003</ArticleId><ArticleId IdType="pubmed">26142125</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R., Santini L., Colantoni A., Peruzzi G., de Turris V., Alfano V., Bozzoni I., Rosa A. FUS Mutant Human Motoneurons Display Altered Transcriptome and MicroRNA Pathways with Implications for ALS Pathogenesis. Stem Cell Rep. 2017;9:1450&#x2013;1462. doi: 10.1016/j.stemcr.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.004</ArticleId><ArticleId IdType="pmc">PMC5830977</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronicki L.M., Jasmin B.J. Emerging Complexity of the HuD/ELAVl4 Gene; Implications for Neuronal Development, Function, and Dysfunction. RNA. 2013;19:1019&#x2013;1037. doi: 10.1261/rna.039164.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.039164.113</ArticleId><ArticleId IdType="pmc">PMC3708524</ArticleId><ArticleId IdType="pubmed">23861535</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchen L.W., Strich S.J. An Hereditary Motor Neurone Disease with Progressive Denervation of Muscle in the Mouse: The Mutant &#x201c;Wobbler&#x201d;. J. Neurol. Neurosurg. Psychiatry. 1968;31:535&#x2013;542. doi: 10.1136/jnnp.31.6.535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.31.6.535</ArticleId><ArticleId IdType="pmc">PMC496420</ArticleId><ArticleId IdType="pubmed">5709840</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohm M., May C., Marcus K., Steinbach S., Theis V., Theiss C., Matschke V. The MicroRNA MiR-375-3p and the Tumor Suppressor NDRG2 Are Involved in Sporadic Amyotrophic Lateral Sclerosis. Cell. Physiol. Biochem. 2019;52:1412&#x2013;1426. doi: 10.33594/000000099.</Citation><ArticleIdList><ArticleId IdType="doi">10.33594/000000099</ArticleId><ArticleId IdType="pubmed">31075191</ArticleId></ArticleIdList></Reference><Reference><Citation>Capauto D., Colantoni A., Lu L., Santini T., Peruzzi G., Biscarini S., Morlando M., Shneider N.A., Caffarelli E., Laneve P., et al. A Regulatory Circuitry Between Gria2, MiR-409, and MiR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons. Mol. Neurobiol. 2018;55:7635&#x2013;7651. doi: 10.1007/s12035-018-0884-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0884-4</ArticleId><ArticleId IdType="pmc">PMC6132778</ArticleId><ArticleId IdType="pubmed">29430619</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Lu Y., Xu X.-L., Gao F.-B. The FTD/ALS-Associated RNA-Binding Protein TDP-43 Regulates the Robustness of Neuronal Specification through MicroRNA-9a in Drosophila. Hum. Mol. Genet. 2013;22:218&#x2013;225. doi: 10.1093/hmg/dds420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds420</ArticleId><ArticleId IdType="pmc">PMC3526156</ArticleId><ArticleId IdType="pubmed">23042786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Guan Y., Chen Y., Zhang C., Yu L., Gao H., Du H., Liu B., Wang X. MiRNA-9 Expression Is Upregulated in the Spinal Cord of G93A-SOD1 Transgenic Mice. Int. J. Clin. Exp. Pathol. 2013;6:1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3759489</ArticleId><ArticleId IdType="pubmed">24040447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M.J., Percy M.E. Neurofilament Light and Polyadenylated MRNA Levels Are Decreased in Amyotrophic Lateral Sclerosis Motor Neurons. J. Neuropathol. Exp. Neurol. 1994;53:221&#x2013;230. doi: 10.1097/00005072-199405000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199405000-00002</ArticleId><ArticleId IdType="pubmed">7909836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishtiaq M., Campos-Melo D., Volkening K., Strong M.J. Analysis of Novel NEFL MRNA Targeting MicroRNAs in Amyotrophic Lateral Sclerosis. PLoS ONE. 2014;9:e85653. doi: 10.1371/journal.pone.0085653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0085653</ArticleId><ArticleId IdType="pmc">PMC3893244</ArticleId><ArticleId IdType="pubmed">24454911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley Z.C.E., Campos-Melo D., Strong M.J. MiR-105 and MiR-9 Regulate the MRNA Stability of Neuronal Intermediate Filaments. Implications for the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS) Brain Res. 2019;1706:93&#x2013;100. doi: 10.1016/j.brainres.2018.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.10.032</ArticleId><ArticleId IdType="pubmed">30385300</ArticleId></ArticleIdList></Reference><Reference><Citation>Haramati S., Chapnik E., Sztainberg Y., Eilam R., Zwang R., Gershoni N., McGlinn E., Heiser P.W., Wills A.-M., Wirguin I., et al. MiRNA Malfunction Causes Spinal Motor Neuron Disease. Proc. Natl. Acad. Sci. USA. 2010;107:13111&#x2013;13116. doi: 10.1073/pnas.1006151107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006151107</ArticleId><ArticleId IdType="pmc">PMC2919953</ArticleId><ArticleId IdType="pubmed">20616011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong C., Liang W., Zhang C., Wang Y., Yang Y., Wang X., Wang S., Huo D., Wang H., Wang D., et al. PAK4 Suppresses Motor Neuron Degeneration in HSOD1G93A-Linked Amyotrophic Lateral Sclerosis Cell and Rat Models. Cell Prolif. 2021;54:e13003. doi: 10.1111/cpr.13003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.13003</ArticleId><ArticleId IdType="pmc">PMC8016643</ArticleId><ArticleId IdType="pubmed">33615605</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Zhang C., Guan Y., Chen Y., Lu Q., Jie L., Gao H., Du H., Zhang H., Liu Y., et al. Screening the Expression Characteristics of Several MiRNAs in G93A-SOD1 Transgenic Mouse: Altered Expression of MiRNA-124 Is Associated with Astrocyte Differentiation by Targeting Sox2 and Sox9. J. Neurochem. 2018;145:51&#x2013;67. doi: 10.1111/jnc.14229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14229</ArticleId><ArticleId IdType="pubmed">28960306</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Kapetis D., Mantegazza R., Baggi F., Bonanno S., Barzago C., Cavalcante P., de Rosbo N.K., Bernasconi P. Altered MiRNA Expression Is Associated with Neuronal Fate in G93A-SOD1 Ependymal Stem Progenitor Cells. Exp. Neurol. 2014;253:91&#x2013;101. doi: 10.1016/j.expneurol.2013.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.12.007</ArticleId><ArticleId IdType="pubmed">24365539</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoivanenko I.S., Matveeva E.A., Gelfand V.I., Goldman R.D., Minin A.A. Mitochondrial Membrane Potential Is Regulated by Vimentin Intermediate Filaments. FASEB J. 2015;29:820&#x2013;827. doi: 10.1096/fj.14-259903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.14-259903</ArticleId><ArticleId IdType="pmc">PMC4422353</ArticleId><ArticleId IdType="pubmed">25404709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekrasova O.E., Mendez M.G., Chernoivanenko I.S., Tyurin-Kuzmin P.A., Kuczmarski E.R., Gelfand V.I., Goldman R.D., Minin A.A. Vimentin Intermediate Filaments Modulate the Motility of Mitochondria. Mol. Biol. Cell. 2011;22:2282&#x2013;2289. doi: 10.1091/mbc.e10-09-0766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e10-09-0766</ArticleId><ArticleId IdType="pmc">PMC3128530</ArticleId><ArticleId IdType="pubmed">21562225</ArticleId></ArticleIdList></Reference><Reference><Citation>Yardeni T., Fine R., Joshi Y., Gradus-Pery T., Kozer N., Reichenstein I., Yanowski E., Nevo S., Weiss-Tishler H., Eisenberg-Bord M., et al. High Content Image Analysis Reveals Function of MiR-124 Upstream of Vimentin in Regulating Motor Neuron Mitochondria. Sci. Rep. 2018;8:59. doi: 10.1038/s41598-017-17878-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17878-x</ArticleId><ArticleId IdType="pmc">PMC5758812</ArticleId><ArticleId IdType="pubmed">29311649</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A.R., Vizinha D., Morais H., Cola&#xe7;o A.R., Loch-Neckel G., Barbosa M., Brites D. Overexpression of MiR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes. Int. J. Mol. Sci. 2021;22:6128. doi: 10.3390/ijms22116128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116128</ArticleId><ArticleId IdType="pmc">PMC8201298</ArticleId><ArticleId IdType="pubmed">34200161</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Bernardini C., Martini M., Baranzini M., Barba M., Musar&#xf2; A. Muscle Expression of SOD1G93A Modulates MicroRNA and MRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice. Front. Cell. Neurosci. 2015;9:463. doi: 10.3389/fncel.2015.00463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00463</ArticleId><ArticleId IdType="pmc">PMC4664730</ArticleId><ArticleId IdType="pubmed">26648847</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Rodent Models of Amyotrophic Lateral Sclerosis. Curr. Protoc. Pharmacol. 2015;69:5.67.1&#x2013;5.67.21. doi: 10.1002/0471141755.ph0567s69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471141755.ph0567s69</ArticleId><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan K., Walter F., Tuffy L.P., Poeschel S., Gallagher R., Haunsberger S., Bray I., Stallings R.L., Concannon C.G., Prehn J.H.M. Endoplasmic Reticulum Stress-Mediated Upregulation of MiR-29a Enhances Sensitivity to Neuronal Apoptosis. Eur. J. Neurosci. 2016;43:640&#x2013;652. doi: 10.1111/ejn.13160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13160</ArticleId><ArticleId IdType="pubmed">26750440</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan K., Mitchem M.R., Jimenez-Mateos E.M., Henshall D.C., Concannon C.G., Prehn J.H.M. Increased Expression of MicroRNA-29a in ALS Mice: Functional Analysis of Its Inhibition. J. Mol. Neurosci. 2014;53:231&#x2013;241. doi: 10.1007/s12031-014-0290-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-014-0290-y</ArticleId><ArticleId IdType="pubmed">24696165</ArticleId></ArticleIdList></Reference><Reference><Citation>Klatt C.L., Theis V., Hahn S., Theiss C., Matschke V. Deregulated MiR-29b-3p Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis. Cells. 2019;8:1077. doi: 10.3390/cells8091077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8091077</ArticleId><ArticleId IdType="pmc">PMC6770833</ArticleId><ArticleId IdType="pubmed">31547454</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Chen Y., Chen X., Wei Q., Cao B., Shang H. Downregulation of MicroRNA-193b-3p Promotes Autophagy and Cell Survival by Targeting TSC1/MTOR Signaling in NSC-34 Cells. Front. Mol. Neurosci. 2017;10:160. doi: 10.3389/fnmol.2017.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00160</ArticleId><ArticleId IdType="pmc">PMC5447700</ArticleId><ArticleId IdType="pubmed">28611587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wei Q., Chen X., Li C., Cao B., Ou R., Hadano S., Shang H.-F. Aberration of MiRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2016;9:69. doi: 10.3389/fnmol.2016.00069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00069</ArticleId><ArticleId IdType="pmc">PMC4987348</ArticleId><ArticleId IdType="pubmed">27582688</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kundu M., Viollet B., Guan K.L. AMPK and MTOR Regulate Autophagy through Direct Phosphorylation of Ulk1. Nat. Cell Biol. 2011;13:132&#x2013;141. doi: 10.1038/ncb2152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2152</ArticleId><ArticleId IdType="pmc">PMC3987946</ArticleId><ArticleId IdType="pubmed">21258367</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Serio A., Arjun A., Bilican B., Daub A., Ando D.M., Tsvetkov A., Pleiss M., Li X., Peisach D., et al. Autophagy Induction Enhances TDP43 Turnover and Survival in Neuronal ALS Models. Nat. Chem. Biol. 2014;10:677&#x2013;685. doi: 10.1038/nchembio.1563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1563</ArticleId><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurita H., Okuda R., Yokoo K., Inden M., Hozumi I. Protective Roles of SLC30A3 against Endoplasmic Reticulum Stress via ERK1/2 Activation. Biochem. Biophys. Res. Commun. 2016;479:853&#x2013;859. doi: 10.1016/j.bbrc.2016.09.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.119</ArticleId><ArticleId IdType="pubmed">27678294</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrushev N., Seidel-Rogol B., Salazar G. Angiotensin II Requires Zinc and Downregulation of the Zinc Transporters ZnT3 and ZnT10 to Induce Senescence of Vascular Smooth Muscle Cells. PLoS ONE. 2012;7:e33211. doi: 10.1371/JOURNAL.PONE.0033211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0033211</ArticleId><ArticleId IdType="pmc">PMC3299759</ArticleId><ArticleId IdType="pubmed">22427991</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurita H., Yabe S., Ueda T., Inden M., Kakita A., Hozumi I. MicroRNA-5572 Is a Novel MicroRNA-Regulating SLC30A3 in Sporadic Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:4482. doi: 10.3390/ijms21124482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21124482</ArticleId><ArticleId IdType="pmc">PMC7350020</ArticleId><ArticleId IdType="pubmed">32599739</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Chen Y., Chen X., Wei Q., Ou R., Gu X., Cao B., Shang H. MicroRNA-183-5p Is Stress-Inducible and Protects Neurons against Cell Death in Amyotrophic Lateral Sclerosis. J. Cell. Mol. Med. 2020;24:8614&#x2013;8622. doi: 10.1111/jcmm.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15490</ArticleId><ArticleId IdType="pmc">PMC7412410</ArticleId><ArticleId IdType="pubmed">32558113</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luna N., Turon-Sans J., Cortes-Vicente E., Carrasco-Rozas A., Ill&#xe1;n-Gala I., Dols-Icardo O., Clarim&#xf3;n J., Lle&#xf3; A., Gallardo E., Illa I., et al. Downregulation of MiR-335-5P in Amyotrophic Lateral Sclerosis Can Contribute to Neuronal Mitochondrial Dysfunction and Apoptosis. Sci. Rep. 2020;10:4308. doi: 10.1038/s41598-020-61246-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-61246-1</ArticleId><ArticleId IdType="pmc">PMC7062873</ArticleId><ArticleId IdType="pubmed">32152380</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung Y.-T., Peng K.-C., Chen Y.-C., Yen Y.-P., Chang M., Thams S., Chen J.-A. Mir-17&#x223c;92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration. Cell Stem Cell. 2019;25:193&#x2013;209.e7. doi: 10.1016/j.stem.2019.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.04.016</ArticleId><ArticleId IdType="pubmed">31155482</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wei Q., Gu X., Chen Y., Chen X., Cao B., Ou R., Shang H. Decreased Glycogenolysis by MiR-338-3p Promotes Regional Glycogen Accumulation Within the Spinal Cord of Amyotrophic Lateral Sclerosis Mice. Front. Mol. Neurosci. 2019;12:114. doi: 10.3389/fnmol.2019.00114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00114</ArticleId><ArticleId IdType="pmc">PMC6514045</ArticleId><ArticleId IdType="pubmed">31133799</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Pradat P.F., Ludolph A.C., Loeffler J.P. Energy Metabolism in Amyotrophic Lateral Sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;amico E., Grosso G., Nieves J.W., Zangh&#xec; A., Factor-Litvak P., Mitsumoto H. Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis. Nutrients. 2021;13:2273. doi: 10.3390/nu13072273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072273</ArticleId><ArticleId IdType="pmc">PMC8308334</ArticleId><ArticleId IdType="pubmed">34209133</ArticleId></ArticleIdList></Reference><Reference><Citation>Caplliure-Llopis J., Peralta-Chamba T., Carrera-Juli&#xe1; S., Cuerda-Ballester M., Drehmer-Rieger E., L&#xf3;pez-Rodriguez M.M., de la Rubia Ort&#xed; J.E. Therapeutic Alternative of the Ketogenic Mediterranean Diet to Improve Mitochondrial Activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review. Food Sci. Nutr. 2020;8:23&#x2013;35. doi: 10.1002/fsn3.1324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.1324</ArticleId><ArticleId IdType="pmc">PMC6977418</ArticleId><ArticleId IdType="pubmed">31993129</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumil E.F., Vohnoutka R.B., Liu Y., Lee S., Shea T.B. Omega-3 Hastens and Omega-6 Delays the Progression of Neuropathology in a Murine Model of Familial ALS. Open Neurol. J. 2017;11:84&#x2013;91. doi: 10.2174/1874205X01711010084.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874205X01711010084</ArticleId><ArticleId IdType="pmc">PMC5748836</ArticleId><ArticleId IdType="pubmed">29387280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathers J.C., Strathdee G., Relton C.L. Induction of Epigenetic Alterations by Dietary and Other Environmental Factors. Adv. Genet. 2010;71:3&#x2013;39. doi: 10.1016/B978-0-12-380864-6.00001-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-380864-6.00001-8</ArticleId><ArticleId IdType="pubmed">20933124</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:1181&#x2013;1194. doi: 10.1007/s12035-014-9070-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9070-5</ArticleId><ArticleId IdType="pubmed">25598354</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Bonanno S., Kapetis D., Barzago C., Cavalcante P., D&#x2019;Alessandro S., Mantegazza R., Bernasconi P. Up-Regulation of Neural and Cell Cycle-Related MicroRNAs in Brain of Amyotrophic Lateral Sclerosis Mice at Late Disease Stage. Mol. Brain. 2015;8:5. doi: 10.1186/s13041-015-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0095-0</ArticleId><ArticleId IdType="pmc">PMC4318136</ArticleId><ArticleId IdType="pubmed">25626686</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Arisi I., D&#x2019;Ambrosi N., Storti A.E., Brandi R., D&#x2019;Onofrio M., Volont&#xe9; C. Dysregulated MicroRNAs in Amyotrophic Lateral Sclerosis Microglia Modulate Genes Linked to Neuroinflammation. Cell Death Dis. 2013;4:e959. doi: 10.1038/cddis.2013.491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.491</ArticleId><ArticleId IdType="pmc">PMC3877562</ArticleId><ArticleId IdType="pubmed">24336079</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Napoli G., Amadio S., Spalloni A., Apolloni S., Longone P., Volonte C. MicroRNA-125b Regulates Microglia Activation and Motor Neuron Death in ALS. Cell Death Differ. 2016;23:531&#x2013;541. doi: 10.1038/cdd.2015.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.153</ArticleId><ArticleId IdType="pmc">PMC5072447</ArticleId><ArticleId IdType="pubmed">26794445</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Siddiqui S., Gabriely G., Lanser A.J., Dake B., Murugaiyan G., Doykan C.E., Wu P.M., Gali R.R., Iyer L.K., et al. Modulating Inflammatory Monocytes with a Unique MicroRNA Gene Signature Ameliorates Murine ALS. J. Clin. Investig. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A.R., Pinto S., Ezequiel C., Cunha C., Carvalho L.A., Moreira R., Brites D. Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions. Front. Cell. Neurosci. 2019;13:109. doi: 10.3389/fncel.2019.00109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00109</ArticleId><ArticleId IdType="pmc">PMC6465643</ArticleId><ArticleId IdType="pubmed">31024256</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Jedrychowski M.P., Cialic R., Krasemann S., Murugaiyan G., Fanek Z., Greco D.J., Wu P.M., Doykan C.E., Kiner O., et al. Targeting MiR-155 Restores Abnormal Microglia and Attenuates Disease in SOD1 Mice. Ann. Neurol. 2015;77:75&#x2013;99. doi: 10.1002/ana.24304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24304</ArticleId><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval E.D., Shaner C., Zhang P., du Maine X., Fischer K., Tay J., Chau B.N., Wu G.F., Miller T.M. Method for Widespread MicroRNA-155 Inhibition Prolongs Survival in ALS-Model Mice. Hum. Mol. Genet. 2013;22:4127&#x2013;4135. doi: 10.1093/hmg/ddt261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt261</ArticleId><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C., Santos C., Gomes C., Fernandes A., Correia A.M., Sebasti&#xe3;o A.M., Vaz A.R., Brites D. Downregulated Glia Interplay and Increased MiRNA-155 as Promising Markers to Track ALS at an Early Stage. Mol. Neurobiol. 2018;55:4207&#x2013;4224. doi: 10.1007/s12035-017-0631-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0631-2</ArticleId><ArticleId IdType="pubmed">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>Giunti D., Marini C., Parodi B., Usai C., Milanese M., Bonanno G., Kerlero de Rosbo N., Uccelli A. Role of MiRNAs Shuttled by Mesenchymal Stem Cell-Derived Small Extracellular Vesicles in Modulating Neuroinflammation. Sci. Rep. 2021;11:1740. doi: 10.1038/s41598-021-81039-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81039-4</ArticleId><ArticleId IdType="pmc">PMC7814007</ArticleId><ArticleId IdType="pubmed">33462263</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasiene J., Yamanaka K. Glial Cells in Amyotrophic Lateral Sclerosis. Neurol. Res. Int. 2011;2011:111&#x2013;120. doi: 10.1155/2011/718987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/718987</ArticleId><ArticleId IdType="pmc">PMC3135155</ArticleId><ArticleId IdType="pubmed">21766027</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A., Myszczynska M.A., Castelli L.M., O&#x2019;Neill B., Kim Y., Talbot J., Nyberg S., Nyamali I., Heath P.R., Stopford M.J., et al. Micro-RNAs Secreted through Astrocyte-Derived Extracellular Vesicles Cause Neuronal Network Degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoye M.L., Regan M.R., Jensen L.A., Lake A.M., Reddy L.V., Vidensky S., Richard J.P., Maragakis N.J., Rothstein J.D., Dougherty J.D., et al. Motor Neuron-Derived MicroRNAs Cause Astrocyte Dysfunction in Amyotrophic Lateral Sclerosis. Brain. 2018;141:2561&#x2013;2575. doi: 10.1093/brain/awy182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy182</ArticleId><ArticleId IdType="pmc">PMC6113638</ArticleId><ArticleId IdType="pubmed">30007309</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenstein I., Eitan C., Diaz-Garcia S., Haim G., Magen I., Siany A., Hoye M.L., Rivkin N., Olender T., Toth B., et al. Human Genetics and Neuropathology Suggest a Link between MiR-218 and Amyotrophic Lateral Sclerosis Pathophysiology. Sci. Transl. Med. 2019;11:eaav5264. doi: 10.1126/scitranslmed.aav5264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aav5264</ArticleId><ArticleId IdType="pmc">PMC7057809</ArticleId><ArticleId IdType="pubmed">31852800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Cunha C., Nascimento F., Ribeiro J.A., Vaz A.R., Brites D. Cortical Neurotoxic Astrocytes with Early ALS Pathology and MiR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model. Mol. Neurobiol. 2019;56:2137&#x2013;2158. doi: 10.1007/s12035-018-1220-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1220-8</ArticleId><ArticleId IdType="pubmed">29995256</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa M., Gomes C., Sequeira C., Gon&#xe7;alves-Ribeiro J., Pina C.C., Carvalho L.A., Moreira R., Vaz S.H., Vaz A.R., Brites D. Recovery of Depleted MiR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons. Front. Cell Dev. Biol. 2021;9:634355. doi: 10.3389/fcell.2021.634355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.634355</ArticleId><ArticleId IdType="pmc">PMC8103001</ArticleId><ArticleId IdType="pubmed">33968923</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway M.J., Andersen P.M., Russ G., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., et al. ANG Mutations Segregate with Familial and &#x201c;sporadic&#x201d; Amyotrophic Lateral Sclerosis. Nat. Genet. 2006;38:411&#x2013;413. doi: 10.1038/ng1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1742</ArticleId><ArticleId IdType="pubmed">16501576</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivello M., Hogg M.C., Jirstr&#xf6;m E., Halang L., Woods I., Rayner M., Coughlan K.S., Lewandowski S.A., Prehn J.H.M. Vascular Regression Precedes Motor Neuron Loss in the FUS (1&#x2013;359) ALS Mouse Model. Dis. Model. Mech. 2019;12:dmm040238. doi: 10.1242/dmm.040238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.040238</ArticleId><ArticleId IdType="pmc">PMC6737946</ArticleId><ArticleId IdType="pubmed">31383794</ArticleId></ArticleIdList></Reference><Reference><Citation>Horak M., Novak J., Bienertova-Vasku J. Muscle-Specific MicroRNAs in Skeletal Muscle Development. Dev. Biol. 2016;410:1&#x2013;13. doi: 10.1016/j.ydbio.2015.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2015.12.013</ArticleId><ArticleId IdType="pubmed">26708096</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen J.M., Manzano R., Oliv&#xe1;n S., Zaragoza P., Garc&#xed;a-Redondo A., Osta R. MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis. PLoS ONE. 2014;9:e89065. doi: 10.1371/JOURNAL.PONE.0089065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0089065</ArticleId><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez G., Heyer M.P., Feng G., Sanes J.R. The Role of Muscle MicroRNAs in Repairing the Neuromuscular Junction. PLoS ONE. 2014;9:e93140. doi: 10.1371/journal.pone.0093140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093140</ArticleId><ArticleId IdType="pmc">PMC3963997</ArticleId><ArticleId IdType="pubmed">24664281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Simonet T., Bauch&#xe9; S., Mandjee N., Malfatti E., Girard E., Tanguy M.-L., Behin A., Khiami F., Sariali E., et al. Muscle Histone Deacetylase 4 Upregulation in Amyotrophic Lateral Sclerosis: Potential Role in Reinnervation Ability and Disease Progression. Brain. 2013;136:2359&#x2013;2368. doi: 10.1093/brain/awt164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt164</ArticleId><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V., Marozzo R., Angelini C. MicroRNAs and HDAC4 Protein Expression in the Skeletal Muscle of ALS Patients. Clin. Neuropathol. 2020;39:105&#x2013;114. doi: 10.5414/NP301233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP301233</ArticleId><ArticleId IdType="pubmed">32000889</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobu&#x15b; A., Baumert B., Litwi&#x144;ska Z., Go&#x142;&#x105;b-Janowska M., St&#x119;pniewski J., Kotowski M., Pius-Sadowska E., Kawa M.P., Gr&#xf3;decka-Szwajkiewicz D., Peregud-Pogorzelski J., et al. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and MiRNA Profiles. Int. J. Mol. Sci. 2018;19:1312. doi: 10.3390/ijms19051312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051312</ArticleId><ArticleId IdType="pmc">PMC5983708</ArticleId><ArticleId IdType="pubmed">29702606</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A.P., Wada S., Vergani L., Hock M.B., Lamon S., L&#xe9;ger B., Ushida T., Cartoni R., Wadley G.D., Hespel P., et al. Disruption of Skeletal Muscle Mitochondrial Network Genes and MiRNAs in Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2013;49:107&#x2013;117. doi: 10.1016/j.nbd.2012.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.08.015</ArticleId><ArticleId IdType="pubmed">22975021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang C., Ji L.L. Role of PGC-1&#x3b1; Signaling in Skeletal Muscle Health and Disease. Ann. N. Y. Acad. Sci. 2012;1271:110&#x2013;117. doi: 10.1111/j.1749-6632.2012.06738.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2012.06738.x</ArticleId><ArticleId IdType="pmc">PMC3499658</ArticleId><ArticleId IdType="pubmed">23050972</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L., J&#xf8;rgensen L.H., Bech R.D., Frandsen U., Schr&#xf8;der H.D. Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis. Biomed Res. Int. 2016;2016:5930621. doi: 10.1155/2016/5930621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5930621</ArticleId><ArticleId IdType="pmc">PMC4852332</ArticleId><ArticleId IdType="pubmed">27195289</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini M., Dobrowolny G., Aucello M., Musar&#xf2; A. Postmitotic Expression of SOD1G93A Gene Affects the Identity of Myogenic Cells and Inhibits Myoblasts Differentiation. Mediators Inflamm. 2015;2015:537853. doi: 10.1155/2015/537853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/537853</ArticleId><ArticleId IdType="pmc">PMC4600922</ArticleId><ArticleId IdType="pubmed">26491230</ArticleId></ArticleIdList></Reference><Reference><Citation>DI Pietro L., Baranzini M., Berardinelli M.G., Lattanzi W., Monforte M., Tasca G., Conte A., Logroscino G., Michetti F., Ricci E., et al. Potential Therapeutic Targets for ALS: MIR206, MIR208b and MIR499 Are Modulated during Disease Progression in the Skeletal Muscle of Patients. Sci. Rep. 2017;7:9538. doi: 10.1038/s41598-017-10161-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10161-z</ArticleId><ArticleId IdType="pmc">PMC5573384</ArticleId><ArticleId IdType="pubmed">28842714</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V., Merico A., Angelini C. Micro-RNAs in ALS Muscle: Differences in Gender, Age at Onset and Disease Duration. J. Neurol. Sci. 2017;380:58&#x2013;63. doi: 10.1016/j.jns.2017.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.008</ArticleId><ArticleId IdType="pmc">PMC5598142</ArticleId><ArticleId IdType="pubmed">28870590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A., Leonardis L., Zidar J., Koritnik B., Dolenc-Groselj L., Ristic Kovacic S., Curk T., Rogelj B. Differential Expression of MicroRNAs and Other Small RNAs in Muscle Tissue of Patients with ALS and Healthy Age-Matched Controls. Sci. Rep. 2018;8:5609. doi: 10.1038/s41598-018-23139-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23139-2</ArticleId><ArticleId IdType="pmc">PMC5884852</ArticleId><ArticleId IdType="pubmed">29618798</ArticleId></ArticleIdList></Reference><Reference><Citation>Malacarne C., Galbiati M., Giagnorio E., Cavalcante P., Salerno F., Andreetta F., Cagnoli C., Taiana M., Nizzardo M., Corti S., et al. Dysregulation of Muscle-Specific Micrornas as Common Pathogenic Feature Associated with Muscle Atrophy in Als, Sma and Sbma: Evidence from Animal Models and Human Patients. Int. J. Mol. Sci. 2021;22:5673. doi: 10.3390/ijms22115673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115673</ArticleId><ArticleId IdType="pmc">PMC8198536</ArticleId><ArticleId IdType="pubmed">34073630</ArticleId></ArticleIdList></Reference><Reference><Citation>Maimon R., Ionescu A., Bonnie A., Sweetat S., Wald-Altman S., Inbar S., Gradus T., Trotti D., Weil M., Behar O., et al. MiR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non&#x2013;Cell-Autonomous Mechanism in ALS. J. Neurosci. 2018;38:5478&#x2013;5494. doi: 10.1523/JNEUROSCI.3037-17.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3037-17.2018</ArticleId><ArticleId IdType="pmc">PMC6001038</ArticleId><ArticleId IdType="pubmed">29773756</ArticleId></ArticleIdList></Reference><Reference><Citation>Fochi S., Giuriato G., De Simone T., Gomez-Lira M., Tamburin S., Del Piccolo L., Schena F., Venturelli M., Romanelli M.G. Regulation of MicroRNAs in Satellite Cell Renewal, Muscle Function, Sarcopenia and the Role of Exercise. Int. J. Mol. Sci. 2020;21:6732. doi: 10.3390/ijms21186732.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186732</ArticleId><ArticleId IdType="pmc">PMC7555198</ArticleId><ArticleId IdType="pubmed">32937893</ArticleId></ArticleIdList></Reference><Reference><Citation>Park D., Kwak S.G., Park J.-S., Choo Y.J., Chang M.C. Can Therapeutic Exercise Slow Down Progressive Functional Decline in Patients With Amyotrophic Lateral Sclerosis? A Meta-Analysis. Front. Neurol. 2020;11:853. doi: 10.3389/fneur.2020.00853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00853</ArticleId><ArticleId IdType="pmc">PMC7438585</ArticleId><ArticleId IdType="pubmed">32903629</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V., Merico A., Angelini C. MyomiRNAs Dysregulation in ALS Rehabilitation. Brain Sci. 2019;9:8. doi: 10.3390/brainsci9010008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci9010008</ArticleId><ArticleId IdType="pmc">PMC6356197</ArticleId><ArticleId IdType="pubmed">30634563</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzo A.F., Lee E.S. Non-Coding RNA: What Is Functional and What Is Junk? Front. Genet. 2015;6:2. doi: 10.3389/fgene.2015.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2015.00002</ArticleId><ArticleId IdType="pmc">PMC4306305</ArticleId><ArticleId IdType="pubmed">25674102</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu S., M&#xfc;ller F., Sanges R. Examples of Sequence Conservation Analyses Capture a Subset of Mouse Long Non-Coding RNAs Sharing Homology with Fish Conserved Genomic Elements. BMC Bioinform. 2013;14:S14. doi: 10.1186/1471-2105-14-S7-S14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-S7-S14</ArticleId><ArticleId IdType="pmc">PMC3633045</ArticleId><ArticleId IdType="pubmed">23815359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulitsky I., Shkumatava A., Jan C.H., Sive H., Bartel D.P. Conserved Function of LincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution. Cell. 2011;147:1537&#x2013;1550. doi: 10.1016/j.cell.2011.11.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.11.055</ArticleId><ArticleId IdType="pmc">PMC3376356</ArticleId><ArticleId IdType="pubmed">22196729</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabili M., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative Annotation of Human Large Intergenic Noncoding RNAs Reveals Global Properties and Specific Subclasses. Genes Dev. 2011;25:1915&#x2013;1927. doi: 10.1101/gad.17446611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.17446611</ArticleId><ArticleId IdType="pmc">PMC3185964</ArticleId><ArticleId IdType="pubmed">21890647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulitsky I., Bartel D.P. LincRNAs: Genomics, Evolution, and Mechanisms. Cell. 2013;154:26&#x2013;46. doi: 10.1016/j.cell.2013.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.06.020</ArticleId><ArticleId IdType="pmc">PMC3924787</ArticleId><ArticleId IdType="pubmed">23827673</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchese F.P., Raimondi I., Huarte M. The Multidimensional Mechanisms of Long Noncoding RNA Function. Genome Biol. 2017;18:206. doi: 10.1186/s13059-017-1348-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-017-1348-2</ArticleId><ArticleId IdType="pmc">PMC5663108</ArticleId><ArticleId IdType="pubmed">29084573</ArticleId></ArticleIdList></Reference><Reference><Citation>Laneve P., Rea J., Caffarelli E. Long Noncoding RNAs: Emerging Players in Medulloblastoma. Front. Pediatr. 2019;7:67. doi: 10.3389/fped.2019.00067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00067</ArticleId><ArticleId IdType="pmc">PMC6426782</ArticleId><ArticleId IdType="pubmed">30923703</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercer T.R., Dinger M.E., Sunkin S.M., Mehler M.F., Mattick J.S. Specific Expression of Long Noncoding RNAs in the Mouse Brain. Proc. Natl. Acad. Sci. USA. 2008;105:716&#x2013;721. doi: 10.1073/pnas.0706729105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0706729105</ArticleId><ArticleId IdType="pmc">PMC2206602</ArticleId><ArticleId IdType="pubmed">18184812</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec G., Martin D., Merkel A., Knowles D.G., et al. The GENCODE v7 Catalog of Human Long Noncoding RNAs: Analysis of Their Gene Structure, Evolution, and Expression. Genome Res. 2012;22:1775&#x2013;1789. doi: 10.1101/gr.132159.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.132159.111</ArticleId><ArticleId IdType="pmc">PMC3431493</ArticleId><ArticleId IdType="pubmed">22955988</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs J.A., Wolvetang E.J., Mattick J.S., Rinn J.L., Barry G. Mechanisms of Long Non-Coding RNAs in Mammalian Nervous System Development, Plasticity, Disease, and Evolution. Neuron. 2015;88:861&#x2013;877. doi: 10.1016/j.neuron.2015.09.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.09.045</ArticleId><ArticleId IdType="pubmed">26637795</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneaux B.J., Goff L.A., Brettler A.C., Chen H.-H., Brown J.R., Hrvatin S., Rinn J.L., Arlotta P. DeCoN: Genome-Wide Analysis of In Vivo Transcriptional Dynamics during Pyramidal Neuron Fate Selection in Neocortex. Neuron. 2015;85:275&#x2013;288. doi: 10.1016/j.neuron.2014.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.024</ArticleId><ArticleId IdType="pmc">PMC4430475</ArticleId><ArticleId IdType="pubmed">25556833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponjavic J., Oliver P.L., Lunter G., Ponting C.P. Genomic and Transcriptional Co-Localization of Protein-Coding and Long Non-Coding RNA Pairs in the Developing Brain. PLoS Genet. 2009;5:e1000617. doi: 10.1371/journal.pgen.1000617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000617</ArticleId><ArticleId IdType="pmc">PMC2722021</ArticleId><ArticleId IdType="pubmed">19696892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S.-Y., Bogu G.K., Soh B.S., Stanton L.W. The Long Noncoding RNA RMST Interacts with SOX2 to Regulate Neurogenesis. Mol. Cell. 2013;51:349&#x2013;359. doi: 10.1016/j.molcel.2013.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.07.017</ArticleId><ArticleId IdType="pubmed">23932716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea J., Menci V., Tollis P., Santini T., Armaos A., Garone M.G., Iberite F., Cipriano A., Tartaglia G.G., Rosa A., et al. HOTAIRM1 Regulates Neuronal Differentiation by Modulating NEUROGENIN 2 and the Downstream Neurogenic Cascade. Cell Death Dis. 2020;11:527. doi: 10.1038/s41419-020-02738-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-02738-w</ArticleId><ArticleId IdType="pmc">PMC7359305</ArticleId><ArticleId IdType="pubmed">32661334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer-Bensch G. Emerging Roles of Long Non-Coding RNAs as Drivers of Brain Evolution. Cells. 2019;8:1399. doi: 10.3390/cells8111399.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8111399</ArticleId><ArticleId IdType="pmc">PMC6912723</ArticleId><ArticleId IdType="pubmed">31698782</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M.-L., Corbier C.J., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E., et al. Loss of C9ORF72 Impairs Autophagy and Synergizes with PolyQ Ataxin-2 to Induce Motor Neuron Dysfunction and Cell Death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford N.J., Heckman M.G., DeJesus-Hernandez M., Baker M.C., Soto-Ortolaza A.I., Rayaprolu S., Stewart H., Finger E., Volkening K., Seeley W.W., et al. Length of Normal Alleles of C9ORF72 GGGGCC Repeat Do Not Influence Disease Phenotype. Neurobiol. Aging. 2012;33:2950.e5&#x2013;2950.e7. doi: 10.1016/j.neurobiolaging.2012.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.07.005</ArticleId><ArticleId IdType="pmc">PMC3617405</ArticleId><ArticleId IdType="pubmed">22840558</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.D., Ichida J.K. C9ORF72 Protein Function and Immune Dysregulation in Amyotrophic Lateral Sclerosis. Neurosci. Lett. 2019;713:134523. doi: 10.1016/j.neulet.2019.134523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134523</ArticleId><ArticleId IdType="pubmed">31568865</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.-L., DeJesus-Hernandez M., van Blitterswijk M.M., Jansen-West K., Paul J.W., Rademakers R., et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to C9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T., Liu Y., Ba&#xf1;ez-Coronel M., Reid T., Pletnikova O., Lewis J., Miller T.M., Harms M.B., Falchook A.E., Subramony S.H., et al. RAN Proteins and RNA Foci from Antisense Transcripts in C9ORF72 ALS and Frontotemporal Dementia. Proc. Natl. Acad. Sci. USA. 2013;110:E4968&#x2013;E4977. doi: 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Lashley T., Norona F.E., Clayton E.L., Ridler C.E., Fratta P., Isaacs A.M. C9orf72 Frontotemporal Lobar Degeneration Is Characterised by Frequent Neuronal Sense and Antisense RNA Foci. Acta Neuropathol. 2013;126:845&#x2013;857. doi: 10.1007/s00401-013-1200-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1200-z</ArticleId><ArticleId IdType="pmc">PMC3830745</ArticleId><ArticleId IdType="pubmed">24170096</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Higginbottom A., Stopford M.J., Highley J.R., Ince P.G., Wharton S.B., Pickering-Brown S., Kirby J., Hautbergue G.M., Shaw P.J. Antisense RNA Foci in the Motor Neurons of C9ORF72-ALS Patients Are Associated with TDP-43 Proteinopathy. Acta Neuropathol. 2015;130:63&#x2013;75. doi: 10.1007/s00401-015-1429-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1429-9</ArticleId><ArticleId IdType="pmc">PMC4468790</ArticleId><ArticleId IdType="pubmed">25943887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A., Frick P., Gr&#xe4;sser F.A., Gendron T.F., Petrucelli L., Cashman N.R., Edbauer D., Kremmer E., Prudlo J., Troost D., et al. Quantitative Analysis and Clinico-Pathological Correlations of Different Dipeptide Repeat Protein Pathologies in C9ORF72 Mutation Carriers. Acta Neuropathol. 2015;130:845&#x2013;861. doi: 10.1007/s00401-015-1476-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1476-2</ArticleId><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabet R., Schaeffer L., Freyermuth F., Jambeau M., Workman M., Lee C.Z., Lin C.C., Jiang J., Jansen-West K., Abou-Hamdan H., et al. CUG Initiation and Frameshifting Enable Production of Dipeptide Repeat Proteins from ALS/FTD C9ORF72 Transcripts. Nat. Commun. 2018;9:152. doi: 10.1038/s41467-017-02643-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02643-5</ArticleId><ArticleId IdType="pmc">PMC5764992</ArticleId><ArticleId IdType="pubmed">29323119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 Repeat Expansion Disrupts Nucleocytoplasmic Transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Zhu Q., Gendron T.F., Saberi S., McAlonis-Downes M., Seelman A., Stauffer J.E., Jafar-nejad P., Drenner K., Schulte D., et al. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron. 2016;90:535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Walsh M.J., Higginbottom A., Robin Highley J., Dickman M.J., Edbauer D., Ince P.G., Wharton S.B., Wilson S.A., Kirby J., et al. Sequestration of Multiple RNA Recognition Motif-Containing Proteins by C9orf72 Repeat Expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Periz G., Simko E.A.J., Shaw P.G., Kim M.S., Maragakis N.J., Troncoso J.C., Pandey A., Sattler R., et al. C9orf72 Nucleotide Repeat Structures Initiate Molecular Cascades of Disease. Nature. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-Mediated ALS and FTD: Multiple Pathways to Disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H., Almeida S., Moore J., Gendron T.F., Chalasani U., Lu Y., Du X., Nickerson J.A., Petrucelli L., Weng Z., et al. Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS. Neuron. 2015;87:1207&#x2013;1214. doi: 10.1016/j.neuron.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC4589299</ArticleId><ArticleId IdType="pubmed">26402604</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T.G., Mizielinska S., Niccoli T., Mitchell J.S., Thoeng A., Ridler C.E., Gr&#xf6;nke S., Esser J., Heslegrave A., Zetterberg H., et al. Sense and Antisense RNA Are Not Toxic in Drosophila Models of C9orf72-Associated ALS/FTD. Acta Neuropathol. 2018;135:445&#x2013;457. doi: 10.1007/s00401-017-1798-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1798-3</ArticleId><ArticleId IdType="pmc">PMC6385858</ArticleId><ArticleId IdType="pubmed">29380049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 Repeat Expansions Cause Neurodegeneration in Drosophila through Arginine-Rich Proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Bento-Abreu A., Gendron T.F., Boeynaems S., Bogaert E., Nuyts R., Timmers M., Scheveneels W., Hersmus N., Wang J., et al. A Zebrafish Model for C9orf72 ALS Reveals RNA Toxicity as a Pathogenic Mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Pattamatta A., Zu T., Reid T., Bardhi O., Borchelt D.R., Yachnis A.T., Ranum L.P.W. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Muhammad A.K.M.G., Gendron T.F., Kim K.J., Austin A., Cady J., Liu E.Y., Zarrow J., Grant S., et al. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD. Neuron. 2015;88:892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Cabrera G.T., Tran H., Gendron T.F., McKeon J.E., Metterville J., Weiss A., Wightman N., Salameh J., Kim J., et al. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice. Neuron. 2015;88:902&#x2013;909. doi: 10.1016/j.neuron.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd D.W., Tomchick D.R., Corey D.R., Gagnon K.T. Pathogenic C9ORF72 Antisense Repeat RNA Forms a Double Helix with Tandem C:C Mismatches. Biochemistry. 2016;55:1283&#x2013;1286. doi: 10.1021/acs.biochem.6b00136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.6b00136</ArticleId><ArticleId IdType="pubmed">26878348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A., Zalar M., &#x160;ket P., Plavec J., Rogelj B. Anti-Sense DNA d(GGCCCC)n Expansions in C9ORF72 Form i-Motifs and Protonated Hairpins. Sci. Rep. 2015;5:17944. doi: 10.1038/srep17944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17944</ArticleId><ArticleId IdType="pmc">PMC4668579</ArticleId><ArticleId IdType="pubmed">26632347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski L.A., Hall A.C., Mekhail K. Ataxin-2: From RNA Control to Human Health and Disease. Genes (Basel) 2017;8:2&#x2013;21. doi: 10.3390/genes8060157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes8060157</ArticleId><ArticleId IdType="pmc">PMC5485521</ArticleId><ArticleId IdType="pubmed">28587229</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulst S.M., Nechiporuk A., Nechiporuk T., Gispert S., Chen X.N., Lopes-Cendes I., Pearlman S., Starkman S., Orozco-Diaz G., Lunkes A., et al. Moderate Expansion of a Normally Biallelic Trinucleotide Repeat in Spinooerebellar Ataxia Type. Nat. Genet. 1996;14:269&#x2013;276. doi: 10.1038/ng1196-269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1196-269</ArticleId><ArticleId IdType="pubmed">8896555</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbert G., Saudou F., Yvert G., Devys D., Trottier Y., Garnier J.-M., Weber C., Mandel J.-L., Cancel G., Abbas N., et al. Cloning of the Gene for Spinocerebellar Ataxia 2 Reveals a Locus with High Sensitivity to Expanded CAG/Glutamine Repeats. Nat. Genet. 1996;14:285&#x2013;291. doi: 10.1038/ng1196-285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1196-285</ArticleId><ArticleId IdType="pubmed">8896557</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 Intermediate-Length Polyglutamine Expansions Are Associated with Increased Risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoshi M., Li Q., Yamamoto M., Okada H., Suzuki Y., Kawahara Y. Direct Binding of Ataxin-2 to Distinct Elements in 3&#x2032; UTRs Promotes MRNA Stability and Protein Expression. Mol. Cell. 2014;55:186&#x2013;198. doi: 10.1016/j.molcel.2014.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.05.022</ArticleId><ArticleId IdType="pubmed">24954906</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P.P., Sun X., Xia G., Arbez N., Paul S., Zhu S., Peng H.B., Ross C.A., Koeppen A.H., Margolis R.L., et al. ATXN2-AS, a Gene Antisense to ATXN2, Is Associated with Spinocerebellar Ataxia Type 2 and Amyotrophic Lateral Sclerosis. Ann. Neurol. 2016;80:600&#x2013;615. doi: 10.1002/ana.24761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24761</ArticleId><ArticleId IdType="pmc">PMC6555153</ArticleId><ArticleId IdType="pubmed">27531668</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalavade R., Griesche N., Ryan D.P., Hildebrand S., Krau&#xdf; S. Mechanisms of RNA-Induced Toxicity in CAG Repeat Disorders. Cell Death Dis. 2013;4:e752. doi: 10.1038/cddis.2013.276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.276</ArticleId><ArticleId IdType="pmc">PMC3763438</ArticleId><ArticleId IdType="pubmed">23907466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lourenco G.F., Janitz M., Huang Y., Halliday G.M. Long Noncoding RNAs in TDP-43 and FUS/TLS-Related Frontotemporal Lobar Degeneration (FTLD) Neurobiol. Dis. 2015;82:445&#x2013;454. doi: 10.1016/j.nbd.2015.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.011</ArticleId><ArticleId IdType="pubmed">26220395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sas-Nowosielska H., Magalska A. Long Noncoding Rnas&#x2014;Crucial Players Organizing the Landscape of the Neuronal Nucleus. Int. J. Mol. Sci. 2021;22:3478. doi: 10.3390/ijms22073478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073478</ArticleId><ArticleId IdType="pmc">PMC8037058</ArticleId><ArticleId IdType="pubmed">33801737</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., K&#xf6;nig J., Hortob&#xe1;gyi T., Nishimura A.L., &#x17d;upunski V., et al. Characterizing the RNA Targets and Position-Dependent Splicing Regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced NcRNAs Allosterically Modify RNA-Binding Proteins in Cis to Inhibit Transcription. Nature. 2008;454:126&#x2013;130. doi: 10.1038/nature06992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06992</ArticleId><ArticleId IdType="pmc">PMC2823488</ArticleId><ArticleId IdType="pubmed">18509338</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., et al. Divergent Roles of ALS-Linked Proteins FUS/TLS and TDP-43 Intersect in Processing Long Pre-MRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoell J.I., Larsson E., Runge S., Nusbaum J.D., Duggimpudi S., Farazi T.A., Hafner M., Borkhardt A., Sander C., Tuschl T. RNA Targets of Wild-Type and Mutant FET Family Proteins. Nat. Struct. Mol. Biol. 2011;18:1428&#x2013;1431. doi: 10.1038/nsmb.2163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2163</ArticleId><ArticleId IdType="pmc">PMC3230689</ArticleId><ArticleId IdType="pubmed">22081015</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen Y.P., Hsieh W.F., Tsai Y.Y., Lu Y.L., Liau E.S., Hsu H.C., Chen Y.C., Liu T.C., Chang M., Li J., et al. Dlk1-Dio3 Locus-Derived LncRNAs Perpetuate Postmitotic Motor Neuron Cell Fate and Subtype Identity. Elife. 2018;7:e38080. doi: 10.7554/eLife.38080.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.38080</ArticleId><ArticleId IdType="pmc">PMC6221546</ArticleId><ArticleId IdType="pubmed">30311912</ArticleId></ArticleIdList></Reference><Reference><Citation>Naganuma T., Nakagawa S., Tanigawa A., Sasaki Y.F., Goshima N., Hirose T. Alternative 3&#x2032;-End Processing of Long Noncoding RNA Initiates Construction of Nuclear Paraspeckles. EMBO J. 2012;31:4020&#x2013;4034. doi: 10.1038/emboj.2012.251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.251</ArticleId><ArticleId IdType="pmc">PMC3474925</ArticleId><ArticleId IdType="pubmed">22960638</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Kukharsky M.S., An H., Dimasi P., Alexeeva S., Shabir O., Heath P.R., Buchman V.L. Protective Paraspeckle Hyper-Assembly Downstream of TDP-43 Loss of Function in Amyotrophic Lateral Sclerosis. Mol. Neurodegener. 2018;13:30. doi: 10.1186/s13024-018-0263-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0263-7</ArticleId><ArticleId IdType="pmc">PMC5984788</ArticleId><ArticleId IdType="pubmed">29859124</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y., Nakagawa S., Hirose T., Okano H.J., Takao M., Shibata S., Suyama S., Kuwako K.I., Imai T., Murayama S., et al. The Long Non-Coding RNA Nuclear-Enriched Abundant Transcript 1-2 Induces Paraspeckle Formation in the Motor Neuron during the Early Phase of Amyotrophic Lateral Sclerosis. Mol. Brain. 2013;6:31. doi: 10.1186/1756-6606-6-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-31</ArticleId><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A., Vest K.E., Pavlath G.K., Corbett A.H. Nuclear Poly(A) Binding Protein 1 (PABPN1) and Matrin3 Interact in Muscle Cells and Regulate RNA Processing. Nucleic Acids Res. 2017;45:10706&#x2013;10725. doi: 10.1093/nar/gkx786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx786</ArticleId><ArticleId IdType="pmc">PMC5737383</ArticleId><ArticleId IdType="pubmed">28977530</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Shibagaki Y., Hattori S., Matsuoka M. C9-ALS/FTD-Linked Proline&#x2013;Arginine Dipeptide Repeat Protein Associates with Paraspeckle Components and Increases Paraspeckle Formation. Cell Death Dis. 2019;10:746. doi: 10.1038/s41419-019-1983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1983-5</ArticleId><ArticleId IdType="pmc">PMC6776546</ArticleId><ArticleId IdType="pubmed">31582731</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukawa K., Kukharsky M.S., Park S.K., Park S., Watanabe N., Iwatsubo T., Hashimoto T., Liebman S.W., Shelkovnikova T.A. Long Non-Coding RNA NEAT1_1 Ameliorates TDP-43 Toxicity in in Vivo Models of TDP-43 Proteinopathy. RNA Biol. 2021:1&#x2013;9. doi: 10.1080/15476286.2020.1860580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1860580</ArticleId><ArticleId IdType="pmc">PMC8583295</ArticleId><ArticleId IdType="pubmed">33427561</ArticleId></ArticleIdList></Reference><Reference><Citation>Biscarini S., Capauto D., Peruzzi G., Lu L., Colantoni A., Santini T., Shneider N.A., Caffarelli E., Laneve P., Bozzoni I. Characterization of the LncRNA Transcriptome in MESC-Derived Motor Neurons: Implications for FUS-ALS. Stem Cell Res. 2018;27:172&#x2013;179. doi: 10.1016/j.scr.2018.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.01.037</ArticleId><ArticleId IdType="pubmed">29449089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Piccolo L., Bonaccorso R., Attardi A., Li Greci L., Romano G., Sollazzo M., Giurato G., Ingrassia A.M.R., Feiguin F., Corona D.F.V., et al. Loss of ISWI Function in Drosophila Nuclear Bodies Drives Cytoplasmic Redistribution of Drosophila TDP-43. Int. J. Mol. Sci. 2018;19:1082. doi: 10.3390/ijms19041082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19041082</ArticleId><ArticleId IdType="pmc">PMC5979594</ArticleId><ArticleId IdType="pubmed">29617352</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.Y., Berson A., Kennerdell J.R., Sartoris A., Unger T., Porta S., Kim H.J., Smith E.R., Shilatifard A., Van Deerlin V., et al. Aberrant Activation of Non-Coding RNA Targets of Transcriptional Elongation Complexes Contributes to TDP-43 Toxicity. Nat. Commun. 2018;9:4406. doi: 10.1038/s41467-018-06543-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06543-0</ArticleId><ArticleId IdType="pmc">PMC6199344</ArticleId><ArticleId IdType="pubmed">30353006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Piccolo L., Yamaguchi M. RNAi of ArcRNA Hsr&#x3c9; Affects Sub-Cellular Localization of Drosophila FUS to Drive Neurodiseases. Exp. Neurol. 2017;292:125&#x2013;134. doi: 10.1016/j.expneurol.2017.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.03.011</ArticleId><ArticleId IdType="pubmed">28342748</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey F., Marcuzzo S., Bonanno S., Bordoni M., Giallongo T., Malacarne C., Cereda C., Zuccotti G.V., Carelli S. Lncrnas Associated with Neuronal Development and Oncogenesis Are Deregulated in Sod1-G93a Murine Model of Amyotrophic Lateral Sclerosis. Biomedicines. 2021;9:809. doi: 10.3390/biomedicines9070809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9070809</ArticleId><ArticleId IdType="pmc">PMC8301400</ArticleId><ArticleId IdType="pubmed">34356873</ArticleId></ArticleIdList></Reference><Reference><Citation>You X., Vlatkovic I., Babic A., Will T., Epstein I., Tushev G., Akbalik G., Wang M., Glock C., Quedenau C., et al. Neural Circular RNAs Are Derived from Synaptic Genes and Regulated by Development and Plasticity. Nat. Neurosci. 2015;18:603&#x2013;610. doi: 10.1038/nn.3975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3975</ArticleId><ArticleId IdType="pmc">PMC4376664</ArticleId><ArticleId IdType="pubmed">25714049</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzman J., Gawad C., Wang P.L., Lacayo N., Brown P.O. Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types. PLoS ONE. 2012;7:e30733. doi: 10.1371/journal.pone.0030733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030733</ArticleId><ArticleId IdType="pmc">PMC3270023</ArticleId><ArticleId IdType="pubmed">22319583</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeck W.R., Sharpless N.E. Detecting and Characterizing Circular RNAs. Nat. Biotechnol. 2014;32:453&#x2013;461. doi: 10.1038/nbt.2890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2890</ArticleId><ArticleId IdType="pmc">PMC4121655</ArticleId><ArticleId IdType="pubmed">24811520</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambra E., Capauto D., Morlando M. Exploring the Regulatory Role of Circular RNAs in Neurodegenerative Disorders. Int. J. Mol. Sci. 2019;20:5477. doi: 10.3390/ijms20215477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20215477</ArticleId><ArticleId IdType="pmc">PMC6862314</ArticleId><ArticleId IdType="pubmed">31689888</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Huang C., Bao C., Chen L., Lin M., Wang X., Zhong G., Yu B., Hu W., Dai L., et al. Exon-Intron Circular RNAs Regulate Transcription in the Nucleus. Nat. Struct. Mol. Biol. 2015;22:256&#x2013;264. doi: 10.1038/nsmb.2959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2959</ArticleId><ArticleId IdType="pubmed">25664725</ArticleId></ArticleIdList></Reference><Reference><Citation>Legnini I., Di Timoteo G., Rossi F., Morlando M., Briganti F., Sthandier O., Fatica A., Santini T., Andronache A., Wade M., et al. Circ-ZNF609 Is a Circular RNA That Can Be Translated and Functions in Myogenesis. Mol. Cell. 2017;66:22&#x2013;37.e9. doi: 10.1016/j.molcel.2017.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.02.017</ArticleId><ArticleId IdType="pmc">PMC5387670</ArticleId><ArticleId IdType="pubmed">28344082</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Huang N., Yang X., Luo J., Yan S., Xiao F., Chen W., Gao X., Zhao K., Zhou H., et al. A Novel Protein Encoded by the Circular Form of the SHPRH Gene Suppresses Glioma Tumorigenesis. Oncogene. 2018;37:1805&#x2013;1814. doi: 10.1038/s41388-017-0019-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-017-0019-9</ArticleId><ArticleId IdType="pubmed">29343848</ArticleId></ArticleIdList></Reference><Reference><Citation>Errichelli L., Dini Modigliani S., Laneve P., Colantoni A., Legnini I., Capauto D., Rosa A., De Santis R., Scarf&#xf2; R., Peruzzi G., et al. FUS Affects Circular RNA Expression in Murine Embryonic Stem Cell-Derived Motor Neurons. Nat. Commun. 2017;8:14741. doi: 10.1038/ncomms14741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14741</ArticleId><ArticleId IdType="pmc">PMC5379105</ArticleId><ArticleId IdType="pubmed">28358055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L.S., Cheng W.C., Chen C.Y., Wu M.C., Wang Y.C., Tseng Y.H., Chuang T.J., Shen C.K.J. Transcriptomopathies of Pre- and Post-Symptomatic Frontotemporal Dementia-like Mice with TDP-43 Depletion in Forebrain Neurons. Acta Neuropathol. Commun. 2019;7:50. doi: 10.1186/s40478-019-0674-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0674-x</ArticleId><ArticleId IdType="pmc">PMC6440020</ArticleId><ArticleId IdType="pubmed">30922385</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Latallo M.J., Zhang Z., Huang B., Bobrovnikov D.G., Dong D., Livingston N.M., Tjoeng W., Hayes L.R., Rothstein J.D., et al. Nuclear Export and Translation of Circular Repeat-Containing Intronic RNA in C9ORF72-ALS/FTD. Nat. Commun. 2021;12:4908. doi: 10.1038/s41467-021-25082-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25082-9</ArticleId><ArticleId IdType="pmc">PMC8363653</ArticleId><ArticleId IdType="pubmed">34389711</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Guida M., Guida M., Coppola C., De Mieri G., Cotrufo R. A MiRNA Signature in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis. Gene. 2012;508:35&#x2013;40. doi: 10.1016/j.gene.2012.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2012.07.058</ArticleId><ArticleId IdType="pubmed">22903028</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R., Regev K., Healy B.C., Mazzola M.A., Beynon V., Von Glehn F., Paul A., Diaz-Cruz C., Gholipour T., Glanz B.I., et al. Correlating Serum Micrornas and Clinical Parameters in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2018;58:261&#x2013;269. doi: 10.1002/mus.26106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi Y.H., Wang H. Exploring MicroRNA Biomarker for Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2018;19:1318. doi: 10.3390/ijms19051318.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051318</ArticleId><ArticleId IdType="pmc">PMC5983737</ArticleId><ArticleId IdType="pubmed">29710810</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M., Nuzziello N., Introna A., Consiglio A., Licciulli F., D&#x2019;Errico E., Scarafino A., Distaso E., Simone I.L. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2018;11:288. doi: 10.3389/fnmol.2018.00288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pmc">PMC6121079</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I., Hama Y., Matsushima M., Hirotani M., Kano T., Hohzen H., Yabe I., Utsumi J., Sasaki H. Identification of Plasma MicroRNAs as a Biomarker of Sporadic Amyotrophic Lateral Sclerosis. Mol. Brain. 2015;8:67. doi: 10.1186/s13041-015-0161-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrade H.M.T., de Albuquerque M., Avansini S.H., de S Rocha C., Dogini D.B., Nucci A., Carvalho B., Lopes-Cendes I., Fran&#xe7;a M.C. MicroRNAs-424 and 206 Are Potential Prognostic Markers in Spinal Onset Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2016;368:19&#x2013;24. doi: 10.1016/j.jns.2016.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.046</ArticleId><ArticleId IdType="pubmed">27538595</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasca E., Pegoraro V., Merico A., Angelini C. Circulating MicroRNAs as Biomarkers of Muscle Differentiation and Atrophy in ALS. Clin. Neuropathol. 2016;35:22&#x2013;30. doi: 10.5414/NP300889.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300889</ArticleId><ArticleId IdType="pubmed">26588026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kmetzsch V., Anquetil V., Saracino D., Rinaldi D., Camuzat A., Gareau T., Jornea L., Forlani S., Couratier P., Wallon D., et al. Plasma MicroRNA Signature in Presymptomatic and Symptomatic Subjects with C9orf72-Associated Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry. 2021;92:485&#x2013;493. doi: 10.1136/jnnp-2020-324647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324647</ArticleId><ArticleId IdType="pmc">PMC8053348</ArticleId><ArticleId IdType="pubmed">33239440</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman R., Mousa N.O., Rashed H.R., Moustafa R.R., Hamdi N., Osman A., Fahmy N. Assessment of Diagnostic Potential of Some Circulating MicroRNAs in Amyotrophic Lateral Sclerosis Patients, an Egyptian Study. Clin. Neurol. Neurosurg. 2021;208:106883. doi: 10.1016/j.clineuro.2021.106883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2021.106883</ArticleId><ArticleId IdType="pubmed">34454204</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K., Mori F., Kakita A., Takahashi H., Utsumi J., Sasaki H. Analysis of MicroRNA from Archived Formalin-Fixed Paraffin-Embedded Specimens of Amyotrophic Lateral Sclerosis. Acta Neuropathol. Commun. 2014;2:173. doi: 10.1186/s40478-014-0173-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0173-z</ArticleId><ArticleId IdType="pmc">PMC4279903</ArticleId><ArticleId IdType="pubmed">25497327</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niel G., D&#x2019;Angelo G., Raposo G. Shedding Light on the Cell Biology of Extracellular Vesicles. Nat. Rev. Mol. Cell Biol. 2018;19:213&#x2013;228. doi: 10.1038/nrm.2017.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.125</ArticleId><ArticleId IdType="pubmed">29339798</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S., Cunha C., Barbosa M., Vaz A.R., Brites D. Exosomes from NSC-34 Cells Transfected with HSOD1-G93A Are Enriched in Mir-124 and Drive Alterations in Microglia Phenotype. Front. Neurosci. 2017;11:273. doi: 10.3389/fnins.2017.00273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00273</ArticleId><ArticleId IdType="pmc">PMC5434170</ArticleId><ArticleId IdType="pubmed">28567000</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A., Gitler A.D. Distinct Repertoires of MicroRNAs Present in Mouse Astrocytes Compared to Astrocyte-Secreted Exosomes. PLoS ONE. 2017;12:e0171418. doi: 10.1371/JOURNAL.PONE.0171418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0171418</ArticleId><ArticleId IdType="pmc">PMC5289606</ArticleId><ArticleId IdType="pubmed">28152040</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q., Zhao Y., Zhou X., Luan J., Cui Y., Han J. Comparison of the Extraction and Determination of Serum Exosome and MiRNA in Serum and the Detection of MiR-27a-3p in Serum Exosome of ALS Patients. Intractable Rare Dis. Res. 2018;7:13&#x2013;18. doi: 10.5582/irdr.2017.01091.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2017.01091</ArticleId><ArticleId IdType="pmc">PMC5849619</ArticleId><ArticleId IdType="pubmed">29552440</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D., Wajnberg G., Roy J., Beauregard A.P., Chacko S., Crapoulet N., Fournier S., Ghosh A., Lewis S.M., Marrero A., et al. Identification of a Circulating MiRNA Signature in Extracellular Vesicles Collected from Amyotrophic Lateral Sclerosis Patients. Brain Res. 2019;1708:100&#x2013;108. doi: 10.1016/j.brainres.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu M., Hama Y., Utsumi J., Takashina K., Yasumatsu H., Mori F., Wakabayashi K., Shoji M., Sasaki H. MicroRNA Expression Profiles of Neuron-Derived Extracellular Vesicles in Plasma from Patients with Amyotrophic Lateral Sclerosis. Neurosci. Lett. 2019;708:134176. doi: 10.1016/j.neulet.2019.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.03.048</ArticleId><ArticleId IdType="pubmed">31173847</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack S.A., Dunlop R.A., Cox P.A. An MiRNA Fingerprint Using Neural-Enriched Extracellular Vesicles from Blood Plasma: Towards a Biomarker for Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Open Biol. 2020;10:200116. doi: 10.1098/rsob.200116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200116</ArticleId><ArticleId IdType="pmc">PMC7333885</ArticleId><ArticleId IdType="pubmed">32574550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pregnolato F., Cova L., Doretti A., Bardelli D., Silani V., Bossolasco P. Exosome MicroRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study. Biomolecules. 2021;11:1220. doi: 10.3390/biom11081220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11081220</ArticleId><ArticleId IdType="pmc">PMC8394507</ArticleId><ArticleId IdType="pubmed">34439885</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D., Gagliardi S., Zucca S., Arigoni M., Giannini M., Garofalo M., Olivero M., Dell&#x2019;Orco M., Pansarasa O., Bernuzzi S., et al. Different MiRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases. Int. J. Mol. Sci. 2021;22:2737. doi: 10.3390/ijms22052737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052737</ArticleId><ArticleId IdType="pmc">PMC7962970</ArticleId><ArticleId IdType="pubmed">33800495</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., M&#xfc;ller K., Ludolph A.C., Weishaupt J.H. Systemic Dysregulation of TDP-43 Binding MicroRNAs in Amyotrophic Lateral Sclerosis. Acta Neuropathol. Commun. 2013;1:42. doi: 10.1186/2051-5960-1-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-42</ArticleId><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Annunziata A., Fiorentino G., Borra M., Biffali E., Coppola C., Cotrufo R., Brettschneider J., Giordana M.L., Dalmay T., et al. MiR-338-3p Is over-Expressed in Blood, CFS, Serum and Spinal Cord from Sporadic Amyotrophic Lateral Sclerosis Patients. Neurogenetics. 2014;15:243&#x2013;253. doi: 10.1007/s10048-014-0420-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0420-2</ArticleId><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni M., Ricci C., Jones A.R., Giannini F., Al-Chalabi A., Battistini S. Identification of MiRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients. Neuro Mol. Med. 2016;18:551&#x2013;560. doi: 10.1007/s12017-016-8396-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-016-8396-8</ArticleId><ArticleId IdType="pubmed">27119371</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Wyles M., Heath P.R., Kazoka M., Wollff H., Shaw P.J., Kirby J. Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed MiRNAs Related to Neural and Glial Activity. Front. Neurosci. 2018;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelick J., Men Y., Jin S., Seo S., Espejo-Porras F., Yang Y. Elevated Exosomal Secretion of MiR-124-3p from Spinal Neurons Positively Associates with Disease Severity in ALS. Exp. Neurol. 2020;333:113414. doi: 10.1016/j.expneurol.2020.113414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113414</ArticleId><ArticleId IdType="pmc">PMC7502520</ArticleId><ArticleId IdType="pubmed">32712030</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamala J.M., Arias-Carrasco R., Sanchez C., Uhrig M., Bargsted L., Matus S., Maracaja-Coutinho V., Abarzua S., van Zundert B., Verdugo R., et al. Genome-Wide Circulating MicroRNA Expression Profiling Reveals Potential Biomarkers for Amyotrophic Lateral Sclerosis. Neurobiol. Aging. 2018;64:123&#x2013;138. doi: 10.1016/j.neurobiolaging.2017.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.12.020</ArticleId><ArticleId IdType="pubmed">29458840</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y., Cui X., Crossman D.K., Hao J., Kazamel M., Kwon Y., King P.H. Muscle MicroRNA Signatures as Biomarkers of Disease Progression in Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2018;114:85&#x2013;94. doi: 10.1016/j.nbd.2018.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.02.009</ArticleId><ArticleId IdType="pmc">PMC5891369</ArticleId><ArticleId IdType="pubmed">29486297</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Martone J., Lepore E., Casola I., Petrucci A., Inghilleri M., Morlando M., Colantoni A., Scicchitano B.M., Calvo A., et al. A Longitudinal Study Defined Circulating MicroRNAs as Reliable Biomarkers for Disease Prognosis and Progression in ALS Human Patients. Cell Death Discov. 2021;7:4&#x2013;14. doi: 10.1038/s41420-020-00397-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-00397-6</ArticleId><ArticleId IdType="pmc">PMC7801652</ArticleId><ArticleId IdType="pubmed">33431881</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheinerman K.S., Toledo J.B., Tsivinsky V.G., Irwin D., Grossman M., Weintraub D., Hurtig H.I., Chen-Plotkin A., Wolk D.A., McCluskey L.F., et al. Circulating Brain-Enriched MicroRNAs as Novel Biomarkers for Detection and Differentiation of Neurodegenerative Diseases. Alzheimers Res. Ther. 2017;9:89. doi: 10.1186/s13195-017-0316-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0316-0</ArticleId><ArticleId IdType="pmc">PMC5679501</ArticleId><ArticleId IdType="pubmed">29121998</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Goodall E.F., Milo M., Cooper-Knock J., Da Costa M., Hobson E., Kazoka M., Wollff H., Heath P.R., Shaw P.J., et al. Serum MiRNAs MiR-206, 143-3p and 374b-5p as Potential Biomarkers for Amyotrophic Lateral Sclerosis (ALS) Neurobiol. Aging. 2017;55:123&#x2013;131. doi: 10.1016/j.neurobiolaging.2017.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrabec K., Bo&#x161;tjan&#x10d;i&#x10d; E., Koritnik B., Leonardis L., Dolenc Gro&#x161;elj L., Zidar J., Rogelj B., Glava&#x10d; D., Ravnik-Glava&#x10d; M. Differential Expression of Several MiRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients. Front. Mol. Neurosci. 2018;11:106. doi: 10.3389/fnmol.2018.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00106</ArticleId><ArticleId IdType="pmc">PMC5893848</ArticleId><ArticleId IdType="pubmed">29670510</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Manfellotto F., Fiorentino G., Annunziata A., Biffali E., Pannone R., Federico A. Wide-Ranging Analysis of MicroRNA Profiles in Sporadic Amyotrophic Lateral Sclerosis Using Next-Generation Sequencing. Front. Genet. 2018;9:310. doi: 10.3389/fgene.2018.00310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00310</ArticleId><ArticleId IdType="pmc">PMC6102490</ArticleId><ArticleId IdType="pubmed">30154826</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinar A., Koritnik B., Glava&#x10d; D., Ravnik-Glava&#x10d; M. Circular RNAs as Potential Blood Biomarkers in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2019;56:8052&#x2013;8062. doi: 10.1007/s12035-019-1627-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1627-x</ArticleId><ArticleId IdType="pmc">PMC6834740</ArticleId><ArticleId IdType="pubmed">31175544</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosaka T., Yamashita T., Teramoto S., Hirose N., Tamaoka A., Kwak S. ADAR2-Dependent A-to-I RNA Editing in the Extracellular Linear and Circular RNAs. Neurosci. Res. 2019;147:48&#x2013;57. doi: 10.1016/j.neures.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2018.11.005</ArticleId><ArticleId IdType="pubmed">30448461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hideyama T., Yamashita T., Aizawa H., Tsuji S., Kakita A., Takahashi H., Kwak S. Profound Downregulation of the RNA Editing Enzyme ADAR2 in ALS Spinal Motor Neurons. Neurobiol. Dis. 2012;45:1121&#x2013;1128. doi: 10.1016/j.nbd.2011.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.033</ArticleId><ArticleId IdType="pubmed">22226999</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffreda A., Nizzardo M., Arosio A., Ruepp M.D., Calogero R.A., Volinia S., Galasso M., Bendotti C., Ferrarese C., Lunetta C., et al. MiR-129-5p: A Key Factor and Therapeutic Target in Amyotrophic Lateral Sclerosis. Prog. Neurobiol. 2020;190:101803. doi: 10.1016/j.pneurobio.2020.101803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2020.101803</ArticleId><ArticleId IdType="pubmed">32335272</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirren E., Aebischer J., Rochat C., Towne C., Schneider B.L., Aebischer P. SOD1 Silencing in Motoneurons or Glia Rescues Neuromuscular Function in ALS Mice. Ann. Clin. Transl. Neurol. 2015;2:167&#x2013;184. doi: 10.1002/acn3.162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.162</ArticleId><ArticleId IdType="pmc">PMC4338957</ArticleId><ArticleId IdType="pubmed">25750921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Yang B., Qiu L., Yang C., Kramer J., Su Q., Guo Y., Brown R.H., Gao G., Xu Z. Widespread Spinal Cord Transduction by Intrathecal Injection of RAAV Delivers Efficacious RNAi Therapy for Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 2014;23:668&#x2013;681. doi: 10.1093/hmg/ddt454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt454</ArticleId><ArticleId IdType="pmc">PMC3888258</ArticleId><ArticleId IdType="pubmed">24108104</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel F., Gernoux G., Cardozo B., Metterville J.P., Toro Cabreja G.C., Song L., Su Q., Gao G.P., ElMallah M.K., Brown R.H., et al. Therapeutic RAAVrh10 Mediated SOD1 Silencing in Adult SOD1G93A Mice and Nonhuman Primates. Hum. Gene Ther. 2016;27:19&#x2013;31. doi: 10.1089/hum.2015.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2015.122</ArticleId><ArticleId IdType="pmc">PMC4741242</ArticleId><ArticleId IdType="pubmed">26710998</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica L., Todeasa S.H., Cabrera G.T., Salameh J.S., ElMallah M.K., Mueller C., Brown R.H., Sena-Esteves M. Adeno-Associated Virus&#x2013;Delivered Artificial MicroRNA Extends Survival and Delays Paralysis in an Amyotrophic Lateral Sclerosis Mouse Model. Ann. Neurol. 2016;79:687&#x2013;700. doi: 10.1002/ana.24618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24618</ArticleId><ArticleId IdType="pmc">PMC5374859</ArticleId><ArticleId IdType="pubmed">26891182</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeler A.M., Zieger M., Semple C., Pucci L., Veinbachs A., Brown R.H., Mueller C., ElMallah M.K. Intralingual and Intrapleural AAV Gene Therapy Prolongs Survival in a SOD1 ALS Mouse Model. Mol. Ther.-Methods Clin. Dev. 2020;17:246&#x2013;257. doi: 10.1016/j.omtm.2019.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2019.12.007</ArticleId><ArticleId IdType="pmc">PMC6962641</ArticleId><ArticleId IdType="pubmed">31970202</ArticleId></ArticleIdList></Reference><Reference><Citation>Martier R., Liefhebber J.M., Miniarikova J., van der Zon T., Snapper J., Kolder I., Petry H., van Deventer S.J., Evers M.M., Konstantinova P. Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-Nuclear Transcripts in ALS and FTD Patients. Mol. Ther.-Nucleic Acids. 2019;14:593&#x2013;608. doi: 10.1016/j.omtn.2019.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.01.010</ArticleId><ArticleId IdType="pmc">PMC6378669</ArticleId><ArticleId IdType="pubmed">30776581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Berry J.D., McKenna-Yasek D.M., Gernoux G., Owegi M.A., Pothier L.M., Douthwright C.L., Gelevski D., Luppino S.D., Blackwood M., et al. SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS. N. Engl. J. Med. 2020;383:151&#x2013;158. doi: 10.1056/NEJMoa2005056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2005056</ArticleId><ArticleId IdType="pubmed">32640133</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>